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In recent times, DNA structures are one of the attractive research targets because 
of their vital biological roles and remarkable therapeutic applications. Specially, G-
quadruplex DNA structures are a very interesting target because of promoter regions, 
human telomeres and aptemers are closely associated with the genetic integrity, cell 
proliferation, aging and cancer. Fundamental understanding of the interactions of small-
molecule ligands or proteins with DNA sequences and their structural effect, binding 
affinities, thermodynamic, kinetic and thermal stability are very crucial. This doctoral 
thesis has uncovered the interaction studies of novel cyclic naphthalene diimide 
derivatives (cNDIs, 1,2) & non-cyclic naphthalene diimide (NDI 3) with double stranded 
DNA (dsDNA) such as calf thymus DNA (CT-DNA), poly[d(A-T)]2, or poly[d(G-C)]2 
and G-quadruplexes DNA such as human telomere DNA (a-core & a-coreTT), promoter 
region’s DNA (c-kit & c-myc) and thrombin-binding aptamer (TBA).  
 
Firstly, I have studied the interaction of newly synthesized cNDIs 1,2 with various 
types of dsDNA to observe the cyclic linker chain effect binding to dsDNA. Secondly, I 
have studied the interaction of 2 with various types of G-quadruplexes DNA to observe 
the specific binding to G-quadruplexes DNA structure. I have studied the interaction of 
NDI 3 with dsDNA and G-quadruplexes DNA as a control.  
 
The interaction of three different types of dsDNA and seven different types G-rich 
oligonucleotides studied with newly synthesize 1,2 and NDI 3 by the physicochemical 
and biochemical method such as UV-Vis spectroscopy, Circular dichroism (CD) 
spectroscopy, Topoisomerase I assay, Stopped-flow kinetics, Thermal melting studies, 
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TRAP assay and FRET-melting assay experiments. 
 
The binding studies between cNDIs 1,2 and DNA duplexes showed affinities in 
the order of 105–106 M-1 using UV-Vis spectroscopic titration with a stoichiometry of one 
cNDI molecule covered four DNA base pairs as a bis-threading intercalation mode of 
binding. The induced CD signal was observed on cNDIs chromophore upon the addition 
of CT-DNA. Topo I isomerase assay showed that 2 can unwind circular dsDNA, it’s also 
indicated the bis-intercalation binding of cNDIs with dsDNA. According to the van’t Hoff 
and Gibbs free energy equation, thermodynamic parameters (ΔG, ΔH, and ΔS) indicated 
that entropy-dependent hydrophobic and endothermic interactions played a major role in 
the reaction between cNDIs and CT-DNA. Stopped-flow analysis showed that 2 slowly 
dissociate from GC base pairs. The salt ion effect analysis showed that upon the 
increasing salt concentration reduced cNDIs binding with dsDNA. Compound 1 showed 
much slower dissociation, a higher binding selectivity and a more entropically favorable 
interaction to dsDNA than 2 because of its longer linker chain. 
 
The binding interactions between G-quadruplex DNA structure and cNDIs 
showed the affinities in the range of 106–107 M−1 orders with a 2:1 stoichiometry. 
Compound 2 showed highest binding affinities to human telomere a-core G-quadruplex 
DNA with 270 times selectivity than dsDNA. The CD spectra of G-quadruplex DNA 
changed upon the addition of cNDIs suggesting the end staking interaction of cNDIs on 
G-tetrad plane. The thermal melting studies indicated that 2 stabilized to G-quadruplexes 
DNA with preference of human telomeric a-core TT. The FRET melting assay also 
showed that 2 highly stabilized with F21T which is an ancestor of human telomere G-
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quadruplex DNA. Compound 2 revealed an effective inhibitor against telomerase activity 
with an IC50 value of 0.9 μM.  
 
Briefly, the finding of this doctoral thesis will contribute to generate new idea to 
design and development suitable DNA binding ligands. The interesting data in the chapter 
4 indicated that 2 is the suitable candidate drug target to G-quadruplexes DNA, it deserves 
for further investigation with cancer cell line.  
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Introduction and Background 
 
1.1. DNA 
DNA (deoxyribonucleic acid) is the crucial component and present in all living 
things, large and small [1]. It is debatably the most complex structure and we are only 
just in the beginning to understand its function and mechanism. DNA is responsible for 
the management and conservation of genetic information of each living things, which is 
transferred genetic information in germ cells from one generation to the next generation. 
It also carries the essential information for proteins required for the operation of biological 
systems. In the last half-century, scientists have begun to study the mechanisms of the 
process surrounding the function of DNA, such as replication, transcription, translation, 
cell cycle mechanism and DNA damage repair. The processes of replication, transcription 
and translation are known as the central dogma of molecular biology (Fig. 1.1) [1].  
 
Fig.1.1. Representation of replication, transcription and translation [1]. 
 
1.2. Components and structure of DNA 
The basic structure of DNA was established by Watson and Crick [2]. DNA 
consists of two complementary polymer strands that intertwine to give a right handed 
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double helix running in anti-parallel directions [3,4]. Each strand is made up of a series 
of units called nucleotides. A nucleotide is made up of a deoxyribose sugar, a phosphate 
and a nitrogen containing base such as adenine (A), guanine (G), thymine (T) and cytosine 
(C). The C1´ position of the deoxyribose sugar attaches with N9 position of adenine (A) 
or guanine (G) or N1 position of thymine (T) or cytosine (C). The deoxyribose sugar 
connected through the 5  ´ hydroxyl group and the 3´ hydroxyl group of phosphate. 
According to Watson-Crick base pairing rules, adenine (A) attaches with thymine (T) by 
two hydrogen bonds and guanine (G) attaches with cytosine (C) by three hydrogen bonds. 
The bases are connected through a flexible sugar phosphate chain. The DNA strand chain 
direction is 5´- to 3´- from top to bottom. The base pairs are not planar, they can twist and 
roll. Double stranded DNA structure mostly stabilizes by the correct base pairing of 
hydrogen bonds. It may destabilize by phosphate repulsion because the negative charge 
of phosphate. High salt concentration protects phosphate repulsion and stabilize the 
double stranded DNA structure. Cationic ligand molecules may have the same role to 
stabilize the DNA structure. DNA structure also may stabilize in solution by hydrophilic 
interactions between the negatively charged phosphate groups and the surrounding 
solvent [1-4].  
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Fig. 1.2. (A) Chemical composition of double stranded DNA and (B) the structure of 
double stranded DNA [2].  
 
1.3. Double stranded DNA: A-DNA, B-DNA and Z-DNA 
A number of different conformations of double helical DNA can be formed by 
rotating various bonds [3,4]. Although the B-form is the most abundant DNA polymorph, 
other conformations can exist under appropriate conditions. The structures of A-DNA, B-
DNA and Z-DNA are shown in Fig. 1.3 [5].  
 
Under physiological conditions, DNA is generally assumed to be in a B-type 
conformation DNA [3]. B-DNA and A-DNA are right handed with 10 and 11 bases per 
turn respectively, Z-DNA is left handed with 12 bases per turn. Z-DNA backbone is not 
smooth, appearing zig-zag [4].  
 
There are two distinguishable grooves running in the length of the DNA: the major 
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and the minor groove., The major groove for B-DNA has a depth of ~8Å and a width of 
~12Å; the minor groove 8Å and 6Å respectively [4]. This means that only small 
molecules, that can twist and interact with the minor groove whereas much larger 
molecules can interact with the major groove. Generally, protein molecules interact with 
DNA major groove and small molecule drugs bind with minor groove [3].  
 
Fig.1.3. The structures of A-DNA, B-DNA and Z-DNA [5].  
 
1.4. G-quadruplex DNA  
Unlike Watson-Crick duplex model, nucleic acids are not simple linear polymers 
in the cell. A fascinating structure is the G-quadruplex DNA composed of four guanines 
interconnected by Hoogsteen hydrogen bond to form tetrameric units. The formation of 
G-quadruplex DNA was proposed in the 1960s. In the presence of K+ or Na+ mono-
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cations, base pairing formed between N7 and C6 amino group of the adjacent guanines, 
and O6 carbonyl of each guanine by Hoogsteen bond [6-8]. 
 
Recently, uncovered the visualization of DNA G-quadruplex structures in human 
chromosomes have amplified the potential application in therapeutics [6].  G-quadruplex 
DNA can be folded different quadruplex forms such as parallel, antiparallel, hybrid or 
mixed hybrid types depending on extrinsic cation and DNA sequence which makes a 
platform for binding and stabilizing by the small molecule drugs [6-8]. 
 
Fig. 1.4. Polymorphism of G-quadruplexes DNA [9]. 
 
1.5. Source of G-quadruplexes DNA 
There are important regions in the human genome have been described to adopt 
G-quadruplex structures such as telomere region, promoter region and aptemers etc. 
 
1.5.1. Human Telomere G-quadruplexes DNA 
Telomeres are found at the terminus of the chromosomes, which is consisted by a 
long double stranded DNA sequence and a short G-rich single stranded sequence [10]. 
Telomeres play a vital role in maintaining genetic stability and cell growth by preventing 
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gene erosion, non-homologous end-end fusion of chromosomes and attack of nuclease. 
G-quadruplex structures form in the human telomeric DNA sequences containing four 
tandem TTAGGG repeats. The G-quadruplexes formed in those sequences have been 
observed to be highly polymorphic and dynamic in nature. Human telomeric DNA 
sequence forms a hybrid type G-quadruplex structure in K+ solution, whereas it forms an 
antiparallel basket type G-quadruplex structure in Na+ solution [11].  
 
Fig. 1.5. Structure and biological roles of telomeres G-quadruplexes DNA [12]. 
  
1.5.2. Promoter region’s G-quadruplexes DNA 
G-quadruplexes structure have been found in several promoter regions of human 
genes, including c-myc, c-kit, VEGF etc. The promoter region genes contain the sequence 
d(GGG GAG GGT GGG GAG GGT GGG GAAGG), which is formed stable G-
quadruplex structure. The G-quadruplex structure in promoter regions has a significant 
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role in transcription regulation [13-15].  
 
 
Fig.1.6. The formation of a G-quadruplex DNA in a promoter region [7].  
 
1.5.3. Aptamers G-quadruplexes DNA 
Aptamers are RNA or single stranded DNA, which can form G-quadruplexes 
structure. Aptamers G-quadruplexes DNA shows pharmacological significance such as a 
26 mer nucleotide named AS1411 5’-d(GGTGGTGGTGGTTGTGGTGGTGGTGG), 
which can inhibit cancer cell proliferation [16,17].  
 
1.6. Binding modes of ligands to DNA  
 
1.6.1. Irreversible binding to DNA 
The irreversible binding of drugs to DNA ability to bind by cross-linking through 
a base. One of the examples of irreversible binding of drugs to DNA is cisplatin [18]. 
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1.6.2. Reversible bindings of small molecules with DNA 
The small molecule drugs bind to DNA reversibly mainly three ways: 
 
1. Electrostatic binding 
2. Groove binding 
3. Intercalation 
 
Fig. 1.7. Schematic representations of binding modes for ligand–duplex DNA [3,18]. 
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1.6.2.1. Electrostatic interactions 
Because of negatively charged of DNA, the positively charged cationic molecules 
bind with DNA through external association by the electrostatic interaction (Fig. 1.7) [3]. 
I have discussed in details at the salt effect analysis section in the chapter 3 about the 
binding of ligand molecules to DNA depends on the concentration of cations in the 
solution.  
 
1.6.2.2. Intercalation 
The planar aromatic molecules insert to the base pairs of DNA and bind with DNA 
generally known as DNA intercalation. There are many ligand molecules have been 
discovered as a DNA intercalator such as proflavine, ethidium bromide, daunomycin etc. 
(Fig. 1.7) [3]. Bis-intercalation of ligands with DNA is one of the attracted field because 
bi-functional molecules interact strongly with both DNA grooves (Fig. 1.7) [3]. 
 
1.6.2.3. Groove binding 
The ligand molecules are associated with DNA at the location of major and/or 
minor groove and bind through van der Waals, hydrophobic and/or hydrogen bonding 
interactions known as DNA groove binding (Fig. 1.7) [3]. 
 
1.6.3. Binding modes between ligands and G-quadruplexes DNA 
The planar aromatic ring molecules can interact with G-quadruplex by end 
stacking on the terminal G-tetrads as well as groove binding and intercalation binding 
with G-quadruplex DNA (Fig.1.8) [12,19].  
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Fig.1.8. Interaction modes between G-Quadruplex DNA structures and ligands [12]. 
 
1.7. Binding of small molecules to double stranded DNA and 
G-quadruplexes DNA 
 
1.7.1. Binding of small molecules to double stranded DNA 
The development of small ligand molecules that bind with target DNA sequence 
selectively are leading to improve anticancer drugs [20,21]. These ligand molecules 
normally bind to target DNA sequence and controlling gene expression. An example of 
DNA binding drug is Pentamidine, which is used for the treatment of the disease of 
pancreatic cancer [22]. This drugs bind non-specifically to DNA, causing damage to 
normal cells, it displays side effects. However, one of the most challenging goals in this 
area is the design of molecules, which will bind to DNA with specific targets. 
 
 
 
 
Page 24 of 117 
 
1.7.2. Binding of small molecules to G-quadruplexes DNA structures 
G-quadruplex DNA structures form with the assembling of telomeric repeat 
(TTAGGG)3 by telomerase in the telomeres of chromosomal end [23]. Most of the cancer 
cells activated by the over expression of telomerase enzyme in cancer cells. So, targeting 
the controlling of telomeric activity has led to the discovery of a novel anticancer drugs. 
Small molecule drugs are the main targets for stabilizing G-quadruplex DNA structure. 
There are a large number of G-quadruplex DNA stabilizing ligands has been discovered 
such as Anthraquinone [24], acridines  [25], perylenes [26], berberine  [27], porphyrins 
[28], and telomestatin derivatives [29]. These molecules are potential telomerase inhibitor. 
Most of the G-quadruplex DNA stabilizing ligands allows binding through π-π overlap 
on the terminal of G-tetrad [30]. Anthraquinone derivatives such as 2,6-disubstituted 
aminoalkylamido anthraquinone BSU-1051 is the first G-quadruplex DNA interactive 
ligands. It shows telomerase inhibition activity with IC50 values 23 µM [31]. The 3,6,9-
trisubstituted acridines shows 30-40 times higher folding to G-quadruplex than duplex 
DNA and telomerase inhibition activity with IC50 values 10-20 nM. A cyclic acridine 
(BOQ1) also shows a potent telomerase inhibitor with IC50 values 0.33 µM [32]. The 
Perelene derivatives such as PIPER shows effective telomerase inhibitor at low micro-
molar concentration. It shows a potent G-quadruplex DNA binding ligands with the 
stoichiometry of 2:1 than DNA duplex [33]. The Berberine derivatives reveal a stronger 
binding affinity to G-quadruplex and highly inhibit telomerase at low micromolar 
concentration [27]. The Napthalene diimide derivatives, NDIs shows high binding 
affinity to G-quadruplex over duplex DNA and telomerase inhibition of at low 
micromolar concentration [34]. The porphyrin derivatives are widely used macrocyclic 
ligands, shows high binding affinity to G-quadruplex DNA than duplex DNA [13,35,36]. 
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Mn-TMPyP4 shows 10,000 fold selectivity to G-quadruplex DNA over duplex DNA and 
a potential telomerase inhibitor with IC50 value 580 nM. It’s also shows the inhibitory 
effect on cancer cell line [37]. Telomestain is a natural compound isolated from 
Streptomyces anulatus, shows telomerase inhibition activity at 5 nM concentration. It’s 
also able to reduce tumor cell growth [38]. Telomestain derivatives such as cyclic 
oxazoles shows structure specific selectivity with parallel c-kit G-quadruplex DNA than 
antiparallel telomeric G-quadruplex DNA [39]. The telomestain derivatives such as 
hexaoxazole containing macrocycle (HXDV) selectively stabilize telomeric G-
quadruplexes DNA structure, whereas it did not show affinity to duplex DNA [40].  
 
 
 
2,6-disubstituted anthraquinone [31] 3,6,9-trisubstituted acridines [32] 
 
 
 
PIPER [33] Piperidino berberine [27] 
  
TMPyP4 porphyrin [35] 
 
Telomestain [39] 
Fig.1.9. Structures of known G-quadruplex ligands. 
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1.8. Methods for the study of ligand interactions with G-
quadruplex and duplex DNA 
The understanding in detail mechanisms of drug-DNA interactions are very 
crucial to the design and discovery of DNA targeting drugs [41]. There are several 
techniques which have been used to investigate drug–DNA interactions, including 
absorption spectroscopy [42], circular dichroism (CD) [43], emission spectroscopy [44], 
calorimetry [45], nuclear magnetic resonance (NMR) [46], surface plasmon resonance 
(SPR) [47], mass spectrometry [48], X-ray diffraction [49], competition dialysis [50], 
TRAP assay [23] and Molecular modeling [51]. 
In particular, the UV-Vis absorption titration have been developed for the binding 
studies to measure binding constant (K) and binding site size (n) [42]. The Stopped flow 
kinetics method have been sued to understand the dissociation constant (kd) and 
association constant (ka) of DNA-ligand interactions [42]. The CD has been used to study 
for characterizing the DNA structure and DNA structural change upon the binding of 
ligands molecules [52]. The Thermal melting studies have been used to know the 
stabilization of DNA-ligand interactions. The Fluorescence Resonance Energy Transfer 
(FRET) assays also have been widely used to study competitive thermal stabilization of 
different types of DNA binding with ligand or different types of ligand binding with DNA 
[53,54]. The Topo I isomerase assay is a powerful technique to study intercalation of 
ligands with circular double stranded DNA. The Telomere repeat amplification protocol 
(TRAP) assay is a widely used technique to know the inhibitory activity of telomerase 
enzyme by the ligand molecules [23]. Nowadays, Computer modeling, simulation is a 
popular technique to study of the interaction of ligands with G-quadruplexes DNA and 
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double stranded DNA [51].  
 
1.9. Binding of naphthalene diimide derivatives to DNA 
Naphthalene diimide derivatives are important DNA binder due to their large 
conjugated planer structure. Napthalene diimide binds with double stranded DNA as a 
threading intercaator. Recently, the several concept has been explored for bis-intercalating 
or polycyclic intercalating or cyclic intercalating derivatives of naphthalene diimide [55-
60]. The interaction of a cyclic naphthalene diimide (cNDI) with DNA shows a unique 
catenated structure that dramatically stabilizes the duplex complex. Over the last few 
years a number of NDI based compounds have been developed in part by exploiting the 
available NDI-G-quadruplexes structures. A new type of macrocyclic naphthalene 
diimide, which is connected through the benzene ring with its substituent, showed 
stabilization and high affinity to G-quadruplexes DNA [61].  
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 Tetrasubstrituted NDI [62]  cNDI derivatives [61]  Tetrasubstrituted NDI [63] 
 
 
 
Tetrasubstritute NDI [64] Tetrasubstrituted NDI [65] Ferrocinyl NDI [66] 
Fig.1.10. Naphthalene diimide derivatives studied the interactions with DNA 
 
1.10. Why cyclic naphthalene diimide derivatives (cNDI)? 
Recently, researchers are searching stabilizing ligands for capable of specific 
binding with a G-quadruplexes DNA. Napthalene diimide (NDI) backbone can intercalate 
to dsDNA. Cyclization of NDI with linker chain through benzene ring, seems to be a 
wonderful idea for the stabilization of G-quadruplexes DNA. Because NDI moiety can 
be stacked on G-tetrad plane and bind with π-π interaction. The cNDI molecule would be 
reduced binding to dsDNA because linker chain and benzene part will protect to bind to 
dsDNA.  
 
So, I have synthesized a series of cNDI derivatives and investigated the interaction 
with various types of DNA targeting to develop G-quadruplexes DNA specific binder 
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whereas reducing the binding to dsDNA.   
 
1.11. The aim of the thesis 
My doctoral research deals with the design and synthesis of new DNA interactive 
compounds and the evaluation of their efficiency in binding and stabilizing the double 
stranded and G-quadruplex DNA structures. In particular, my efforts have been directed 
towards the synthesis of macrocyclic naphthalene diimide derivatives (cNDI), where 
cNDI derivatives are designed by different length of linker chain through benzene.  
 
In the last few years, several macrocycles were synthesized for binding with DNA 
specially G-quadruplexes DNA. A natural macrocyclic Telomestsian strongly stabilized 
G-quadruplexes DNA and inhibit telomerase in low concentration [29]. Porphyrins 
derivatives showed 10,000 times selectivity to G-quadruplexes DNA over duplex DNA 
[37]. Recently, NDI based macrocyclic compound showed high stabilization with G-
quadruplexes DNA [61].  
 
In this context, our interest has been devoted to the design of new cNDI 
macrocycles, considering the structure based stabilization with G-quadruplexes DNA and 
reducing the binding with dsDNA. In particular, I have targeted to optimize stacking 
interactions between the cNDI and terminal G-tetrad. So, I have deigned a shorter chain 
cNDI to specific binding model for G-tetrad.  
 
An array of biophysical and biochemical techniques, ultraviolet-visible (UV-Vis), 
Circular Dichroism (CD), Stopped-flow, FRET melting assay, Topo I isomerase assay, 
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TRAP assay and Computer modeling were utilized. The mode of binding, binding 
affinities, thermodynamics, kinetics, thermal melting, telomerase inhibition assay and 
Computer modeling with various DNA sequences are discussed. This dissertation is 
divided into five chapters which are described below:  
 
Chapter 1 is the current chapter, gives a general introduction to targeting DNA 
with small molecules as an effective strategy for drug design.  
 
Chapter 2 is a reproduce work from M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. 
Takenaka, Bioorganic Med. Chem. 23 (2015) 4769–4776 and describes the synthesis of 
cNDI derivaties 1-3.  
 
Chapter 3 is a reproduce work from M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. 
Takenaka, Bioorganic Med. Chem. 23 (2015) 4769–4776 and describes the binding 
studies, kinetic and thermodynamic analysis of cNDIs with ds DNA. 
 
Chapter 4 is a reproduce work from M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. 
Takenaka, Molecule 20 (2015) 10963-10979 and describes the binding studies, thermal 
stability and telomerase inhibition of cNDIs with different types of G-quadruplexes DNA. 
 
Chapter 5 is a reproduce work from M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. 
Takenaka, Bioorganic Med. Chem. 23 (2015) 4769–4776 & M.M. Islam, S. Fujii, S. Sato, 
T. Okauchi, S. Takenaka, Molecule, 20 (2015) 10963-10979 and described the conclusion 
and the perspective of this thesis.  
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Synthesis of cyclic naphthalene diimide 1, 2 and 3 
 
Contents of this chapter have been published in the Bioorgamic & Medicinal chemistry 
Journal (M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. Takenaka, Bioorganic Med. Chem. 
23 (2015) 4769–4776). The materials of the chapter have been reproduced with the 
permission of the Bioorgamic & Medicinal chemistry Journal [1]. 
 
2.1.1. Synthesis of cyclic naphthalene diimide 1 and 2 
 
As precursors of 1 and 2, N,N’-bis[[4-(3-aminopropyl)piperazinyl]propyl]-
naphthalene-1,4,5,8-tetracarboxylic acid diimide (4) and N, N'-bis[3-(3-
aminopropyl)methylaminopropyl] naphthalene-1,4,5,8-tetracarboxylic acid diimide (5) 
were synthesized according to the procedure reported previously [2]. 
 
 
2.1.2. Synthesis of 1 (cNDI 1) 
   A solution of 4 1.0 g (1.5 mmol), terephthalic acid 0.25 g (1.5 mmol), 
triethylamine 12 mL, 1-hydroxybenzotriazole (HOBt) 0.60 g (4.5 mmol), 1H-
Benzotriazol-1-yloxy-tri(pyrrolidino) phosphonium hexafluorophosphate (PyBOP) 
2.3 g (4.5 mmol) in CHCl3 500 mL was stirred at room temperature and the progress 
of this reaction was monitored by TLC on silica gel with mixture of CHCl3: 
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diethylamine = 10: 1.0 as developing agent. After 48 h stirring where the TLC spot of 
NDI (Rf=0) was disappeared, the reaction mixture was evaporated under reduced 
pressure and the residue was dissolved with 20 mL CHCl3. After filtration and 
subsequently evaporation under reduced pressure, the residue was chromatographed 
on a silica gel column (Merck 60) using the eluent consisted of CHCl3: diethylamine 
= 10: 1.0. The fraction of Rf= 0.33 was collected and the solvent was removed under 
reduced pressure. The obtained residue was recrystallized from ethyl acetate, and 1 
was obtained as brown crystal with 0.11 g (yield, 10%). MALDI-TOFMS (positive 
mode, α-CHCA) m/z =763.73 (theory for C42H50N8O6+H+= 763.90). 1H NMR (250 
MHz, CDCl3, TMS) δ1.54 (8H, m), 1.98 (4H, t, J = 6.0 Hz), 2.15 (6H, m), 2.29 (12H, 
m), 2.48 (4H, t, J=6.5 Hz), 3.44 (4H, m), 4.35 (4H, m, J = 6.0 Hz), 7.80 (4H, s), and 
8.77(4H, s) ppm; HRMS Calcd. for C42H50N8O6+H+: M, 763.55. Found: m/z 763.55. 
1 mM 1 aqueous solution was prepared as estimated from the molar absorptivity of 
28800 cm-1M-1 at 384 nm. 
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Fig. 2.1. Reversed phase HPLC of 1. The concentration of acetonitrile was changed 
linearly to 100% from 28% in water containing 0.1% trifluoroacetic acid over 40 min at 
40 ˚C. 
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Fig. 2.2. 1H-NMR chart of 1 in CDCl3 using TMS as internal standard. 
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Fig. 2.3. High-resolution mass spectra (HRMS-FAB) of 1. 
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2.1.3. Synthesis of 2 (cNDI 2)  
   A solution of 5 1.1 g (0.9 mmol), terephthalic acid 0.15 g (0.9 mmol), 
triethylamine 15 mL, 1-hydroxybenzotriazole (HOBt) 0.12 g (0.9 mmol), 1-Ethyl-3-(3-
dimethylaminopropyl)-carbodiimide hydrochloride 0.17 g (0.09 mmol) in CHCl3 400 mL 
was stirred at room temperature and the progress of this reaction was monitored by TLC 
on silica gel with mixture of CHCl3: diethylamine : Methanol = 10 : 0.2 : 1.0 as developing 
agent. After 48 h stirring, the reaction mixture was evaporated under reduced pressure 
and the residue was dissolved with 100 mL CHCl3. After filtration and subsequently 
washed with sat. NaHCO3 aq. (80 ml×5), and dried over magnesium sulfate. The solvent 
was removed and the residue was chromatographed on a silica gel column (Merck60) 
using the eluent of CHCl3: diethylamine : Methanol = 10 : 0.2 : 1.0. The fraction of Rf= 
0.41 was collected and the solvent was removed under reduced pressure. The obtained 
residue was recrystallized from ethyl acetate, and 2 was obtained as brown crystal with 
17 mg (yield, 3%). MALDI-TOFMS (positive mode, α-CHCA) m/z =653.54 (theory for 
C36H40N6O6+H+= 653.302). 1H NMR (500 MHz, CDCl3, TMS) 4H, m), 1.5 (4H, 
t, J=5.9), 1.87 (4H, m), 2.09 (6H, s), 2.31 (4H, m) 3.16 (4H, m), 4.12 (4H, t, J=6.8), 7.12 
(2H, s), 7.56 (4H, s), 8.71 (4H, s) ppm.  HRMS Calcd. for C36H40N6O6+H+: M, 653.302. 
Found: m/z 653.302. 1 mM 2 aqueous solution was prepared as estimated from the molar 
absorptivity of 28800 cm-1M-1 at 384 nm. 
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Fig. 2.4. Reversed phase HPLC of 2. The concentration of acetonitrile was changed 
linearly to 100% from 29% in water containing 0.1% trifluoroacetic acid over 40 min at 
40 ˚C. 
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Fig. 2.5. 1H-NMR chart of 2 in CDCl3 using TMS as internal standard. 
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Fig. 2.6. High-resolution mass spectra (HRMS-EI+) of 2. 
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2.2. Synthesis of NDI 3 
Details of non-cyclic NDI 3 synthesis was asper method previously described [3]. 
 
2.3. References  
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3. F.A. Tanious, S.F. Yen, W.D. Wilson, Kinetic and Equilibrium Analysis of a 
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Thermodynamics and Kinetic Studies in the 
Binding Interaction of Cyclic Naphthalene 
Diimide Derivatives with Double Stranded DNAs 
 
Contents of this chapter have been published in the Bioorgamic & Medicinal chemistry 
Journal (M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. Takenaka, Bioorg. Med. Chem. 23 
(2015) 4769–4776). The materials of the chapter have been reproduced with the 
permission of the Bioorgamic & Medicinal chemistry Journal [1]. 
 
3.1. Introduction 
Small molecules that bind to DNA affect numerous functions of living organisms, 
such molecules have potential as therapeutic agents that function by controlling gene 
expression. Thus, the study of interactions between DNA and small molecules is vital in 
chemical and biological drug discovery research [2,3]. It is important to study the 
thermodynamics and kinetics of the interactions between small molecules and DNA in 
order to understand the binding modes of these molecules and develop new, effective, 
DNA-targeted drugs [2]. Accordingly, many small molecule drugs that interact with DNA 
have been investigated [4]. A classical intercalating drug slides between adjacent base 
pairs of a DNA duplex and forms a stable complex, resulting to mutations, such as 
frameshift [6]. A threading intercalating drug is a new type of intercalator; in its 
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interaction with DNA, two substituents of the molecule are located on the major and 
minor grooves of the DNA duplex, preventing dissociation [3]. Nogalamycin is a typical 
threading intercalator, and its antitumor activity is correlated with its DNA dissociation 
rate constant [3]. This exemplifies the relationship between physical data and biological 
activity. It also shows the importance of physical studies of the interactions between small 
molecules and DNA duplexes. 
 
Expanding on threading intercalating drugs, bis-intercalators have also been 
utilized to stabilize the DNA complex [2-5]. Chaires et al. developed the bis-intercalating 
drug daunomycin [3]. Like nogalamycin, this molecule’s slower dissociation rate 
correlates with its biological activity. Recently, the same concept has been explored for 
bis-intercalating or cyclic intercalating derivatives of naphthalene diimide [6-11]. The 
interaction of a cyclic naphthalene diimide with DNA shows a unique catenated structure 
that dramatically stabilizes the complex. A new type of cyclic naphthalene diimide, 1, 
which is connected with its substituent through the benzene ring, can stabilize both a DNA 
duplex and a DNA tetraplex [12,13]. In recent years, the synthesis of bis-intercalators has 
drawn considerable attention because of the drugs’ potential superiority over mono-
intercalators. Higher DNA-binding constants, slower dissociation rates, and substantial 
sequence selectivity can be expected from the incorporation of two or more intercalating 
units into a polyfunctional ligand [7,8].  
 
Researchers have already reported that naphthalene diimide derivatives act as 
DNA-targeting anticancer agents, and such derivatives have shown potent activity against 
cancer cell lines and telomerase [14,15]. Depending on the substituents, naphthalene 
Page 51 of 117 
 
diimide derivatives have shown selectivity toward AT- or GC-rich regions of DNA [5,7]. 
Our group previously published our synthesis and evaluation of the binding of G-
quadruplex and dsDNA with 1 and other cNDIs [12,13]. In the present study, the 
interaction of 1 and the newly designed 2 with dsDNA was analyzed by UV-Vis 
spectroscopy, CD spectroscopy, a topoisomerase I assay, and stopped-flow kinetics to 
characterize differences in binding mode and binding selectivity. 
 
 
Fig. 3.1. Chemical structure of cNDI 1, 2 and NDI 3 
 
3.2. Experimental procedure 
 
3.2.1. Materials 
CT-DNA, poly[d(A-T)]2, and poly d[(G-C)]2 synthetic polymers were obtained 
from Sigma-Aldrich (St. Louis, MO). Following the extinction coefficients (ε) were used 
for quantification of the nucleic acid solutions: 12824 M-1 cm-1 for CT-DNA, 13200 M-1 
cm-1 for poly[d(A-T)]2, and 16800 M-1 cm-1 for poly[d(G-C)]2. Details of the synthesis 
procedure for 1 and 2 are described in the supplementary data, and 3 was synthesized as 
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previously described [16]. I obtained 2.0 M KCl and 5.0 M NaCl aqueous solutions from 
Life Technologies (Carlsbad, CA), 1.0 M Tris-HCl (pH 7.4) buffer from Sigma-Aldrich 
(St. Louis, MO), and 2-Morpholinoethanesulfonic acid (MES) from Dojindo (Japan). 
 
3.2.2. UV-Vis titration experiments 
Absorption spectra were measured using the Hitachi U-3310 spectrophotometer 
with a 1-cm path-length quartz cell and were recorded in the 200–600 nm range at 25°C. 
UV-Vis absorption titrations were carried out by the stepwise addition of 3 mM/base pair 
of CT-DNA, poly[d(A-T)]2, or poly[d(G-C)]2 to a UV cell containing 6.7 µM solutions of 
1–3. The measurements were performed in 10 mM MES buffer (pH 6.25) containing 100 
mM NaCl and 1 mM EDTA. Binding data, which were obtained by spectrophotometric 
titration of increasing concentrations of each drug to a fixed concentration of DNA, were 
analyzed by Scatchard plot analysis of r/C versus r, according to the excluded-site model 
of the McGhee-von Hippel equation [17] (Eq. 3.1). The binding data were analyzed with 
KaleidaGraph software, using the Levenberg-Marquardt algorithm to determine 
parameters Kb and n. 
 
3.2.3. Thermodynamics analysis  
The effect of temperature on ligand binding affinity was investigated to derive the 
thermodynamic functions of ligand-DNA complex formation. Absorption spectra were 
measured at 20, 22.5, 25, and 27.5°C. Titrations were performed under conditions similar 
to those used in the UV-Vis titration experiments. Enthalpy change (△H) and entropy 
change (△S) were measured by the van’t Hoff equation plotted against lnK versus 1/T 
(Eq. 3.2). The free energy change (△G) was estimated by the Gibbs free energy equation 
(Eq. 3.3). 
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3.2.4. Salt effect analysis 
Salt-dependent Scatchard analysis was conducted at five different concentrations 
of sodium salt: 50, 75, 100, 125, and 150 mM. Titrations were performed under similar 
conditions as those used for the UV-Vis titration experiments. The strength of electrostatic 
interactions of the ligand was determined by plotting the negative logarithm of the sodium 
salt concentration (log [Na+]) against the binding constant (log K) (Eq. 3.4). 
 
3.2.5. Stopped flow kinetics experiments 
Stopped-flow kinetic experiments were performed with the SF-61 DX2 double 
mixing stopped-flow system (Hi-Tech Scientific Inc., Salisbury, UK) equipped with a 
Lauda RF206 temperature controller. Samples were prepared in a buffer solution (10 mM 
MES, 1 mM EDTA, and 0.1 M NaCl; pH 6.25). Absorbance was measured at the 
maximum absorption of the cNDI derivatives. Association rate constants of the ligand-
dsDNA interactions were obtained by fitting the exponential traces of absorbance 
observed after mixing the ligand solution with DNA at a 10-fold excess of the ligand 
concentration. The dual-exponential equation was used for nonlinear fitting: A1 exp(k1t) 
+ A2 exp(k2t), where A and k refer to the fractional amplitudes and rate constants, 
respectively. The intrinsic second-order association rate constant (ka) and the dissociation 
rate constants (kd) were obtained from the slope and intercept of a plot of the apparent 
association rate constant (kapp = A1k1 + A2k2) against the DNA concentration, according to 
the equation kapp = ka[DNA] + kd. The dissociation rate constant (kd) of the ligand from 
DNA was independently determined by sodium dodecyl sulfate (SDS)-driven 
dissociation measurements, as described previously [15,16]. Equal volumes of 1% SDS 
solution and the DNA-ligand complex were mixed instantaneously using a piston pump. 
Changes in absorbance over time were recorded. When the DNA-ligand complex was 
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mixed with SDS solution, the free ligand underwent incorporation into the SDS micelles. 
As this reaction is diffusion-controlled, all absorption changes represent a kd-dependent 
process; therefore nonlinear fitting of the kinetic trace provides the kd value. 
 
3.2.6. Topoisomerase I assay measurements 
A Topoisomerase I assay was carried out according to the method previously 
reported [12,13]. Briefly, 0.25 μg of pUC19 was incubated with 5 U of topoisomerase I 
in 0.1% bovine serum albumin (BSA) and 1× reaction buffer—composed of 35 mM Tris-
HCl (pH 8.0), 72 mM potassium chloride, 5 mM magnesium chloride, 5 mM 
dithiothreitol (DTT), and 5 mM spermidine—at 37°C for 5 min. Various concentrations 
of 1–3 were then added, and the mixture was incubated at 37°C for 1 h. The reaction was 
terminated by the addition of 2 μL of 10% sodium dodecylsulfate (SDS) and 0.5 µL of 
20 mg/ml proteinase K, and the solution was then incubated at 37°C for 15 min. 
Topoisomerase I was then extracted with phenol containing chloroform and isoamyl 
alcohol, and then with chloroform containing isoamyl alcohol. After ethanol precipitation 
and dissolution, topoisomerase I was analyzed by gel electrophoresis on 1% agarose in 
1× TAE at 18 V for 3.5 h. The gel was stained with Gelstar (Takara Bio, Shiga, Japan) in 
1× TAE for 30 min. 
 
3.2.7. Circular dichroism (CD) measurements 
Various concentrations (5–50 µM) of 1–3 were added to 100 μM/base pair CT-
DNA in 10 mM MES buffer (pH 6.25) containing 100 mM NaCl and 1 mM EDTA at 
25°C. CD spectra were taken at a scan rate of 50 nm/min on a Jasco J-820 
spectropolarimeter (Tokyo, Japan). Scan parameters were as follows: response = 2 s, data 
interval = 0.1 nm, sensitivity = 100 mdeg, band width = 2 nm, and scan number = 4. 
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3.2.8. Computer modeling  
Molecular models of the cNDI-DNA complexes were constructed by MOE 
2011.10 (http://www.chemcomp.com/). Compounds 1 or 2 was placed on the binding site 
of the DNA duplex, and energy minimization of the complex was carried out. Molecular 
dynamics calculation of the mineralized complex was further carried out until 1 or 2 was 
stabilized in the binding site. Finally, energy minimization of the complex was obtained, 
as shown in Fig. 6. These calculations were performed using the force field of MMFF94x. 
 
3.3. Result and discussions 
 
3.3.1. Binding studies of cNDIs- dsDNAs: UV-Vis titrations  
Spectroscopic titration of cNDIs with dsDNAs was carried out. The interaction 
showed maximum absorption at 383 nm and a large hypochromic effect with a small 
redshift, indicative of binding between the cNDIs and the dsDNAs (Fig. 3.3). An example 
of the spectrophotometric titration of 1 with CT-DNA is illustrated in Fig. 3.2A. The 
observed hypochromic effect indicated strong intercalative binding of cNDIs between 
dsDNAs. Optical data of the cNDIs are shown in Table 3.2. An isosbestic point observed 
at 395 nm supports the prediction of a two-state system involving bound and free cNDIs. 
Absorbance at a specific wavelength indicated the participation of both free and bound 
cNDIs when titrated with a fixed concentration of DNA. Scatchard plots were prepared 
using absorption changes at the specific wavelength 383 nm upon the addition of various 
concentrations of dsDNA. I used the data in a range of approximately 30%–80% bound 
region of cNDIs and dsDNA. The Scatchard plot in Fig. 3.2B illustrates binding between 
the cNDIs and dsDNAs. It was analyzed using the McGhee-von Hippel equation [17] (Eq. 
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3.1) for non-cooperative ligand binding.  
𝑣
Ｃ
= 𝐾(1 − 𝑛𝑣)(
1−𝑛𝑣
1−(𝑛−1)𝑣
)𝑛−1                                                   (3.1) 
𝑣 is the stoichiometry (the number of ligand molecules bound per moles of base 
pair), C is the free ligand concentration, K is the observed binding constant (Kb), and n is 
the number of base pairs excluded by the binding of a single ligand molecule. The solid 
line in 3.2B indicates a good fit of the experimental values to those predicted by the 
McGhee-von Hippel equation. Scatchard analysis using the spectra change of cNDIs upon 
the addition of dsDNAs showed binding constants ranging from 1.0–53.4×105 M-1, and 
the observed binding order was poly[d(G-C)]2 > CT-DNA > poly[d(A-T)]2. The expected 
value of n was four, as cNDIs interact with dsDNAs by bis-intercalation of four base pairs, 
whereas the threading intercalator 3 followed the nearest-neighbor exclusion principle 
[17], in which it was bound with dsDNAs by intercalation of two base pairs. I expected a 
violation of the nearest-neighbor exclusion principle by the cNDIs because they are large, 
cyclic macromolecules; a single cNDI molecule may cover more than two DNA base 
pairs and bind with dsDNA in bis-intercalative mode. Previous reports [12,13] on the 
binding of NDI derivatives to DNAs have shown similar trends of spectral change and 
support the binding constant for 3 observed here. Previously, our group reported that the 
interaction between 1 and duplex oligonucleotides revealed a higher binding constant (3.7 
× 106 M-1) and melting temperature than did the interaction between 3 and duplex 
oligonucleotides [12]. I further studied 1–3 with different types of dsDNA that carried 
AT- or GC-rich sequences to determine the sequence specificity of binding. Compounds 
1 and 2 showed similar trends of binding behavior with the different types of dsDNA. 
Compounds 1 and 2 showed comparatively higher binding affinity to dsDNAs than 3 
(Table 3.1) because of the binding flexibility of 3. The NDI moiety of 3 may intercalate 
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between dsDNA base pairs, and does not depend on major and minor groove binding. On 
the other hand, cNDI intercalated with the major and minor grooves of dsDNA making a 
rigid catenane complex [9]. Our observations revealed that long-chain 1 has a higher 
binding affinity to dsDNAs than short-chain 2. According to computer modeling, short-
chain 2 may have a steric strain effect in its binding with dsDNA. In addition, Sato et al. 
previously reported that the introduction of a methyl or alkyl group results in a higher 
binding constant because of the substituent effect [18]. Our group has already reported 
that other types of short-chain cNDI derivatives may have a greater affinity for G-
quadruplex DNA than for DNA duplex because of the staking interaction between the 
short-chain cNDI derivatives and G-quadruplex DNA [13]. Compound 1 displayed the 
highest affinity for poly[d(G-C)]2, with a binding constant of 5.34×106 M-1, which is 
approximately 9 times higher than the binding constant of its interactions with CT-DNA 
and Poly[d(A-T)]2 (Table 2). There is a strong tendency for cNDIs to bind with GC base 
pairs because of the rigidity, depth, and width of the GC groove. Nucleophilic guanine 
may also have a strong affinity for protonated cNDI molecules [19]. I assumed that cNDIs 
may strongly intercalate 5′-GpC-3′ sequences by insertion of the naphthalene diimide 
moiety and benzene ring into the 5′-GC/CG-3′ step, creating a catenane structure with 
dsDNA [20]. Preferential interactions of NDI ligands with GC polymers have been 
observed previously, confirming that the binding affinity of NDIs varies with DNA 
sequence [21]. Additionally, the double-stranded DNA structure is known to be highly 
dynamic in solution, with base pairs opening and reforming rapidly at room temperature. 
cNDIs may be able to exploit this millisecond “breathing” behavior of dsDNA by sliding 
between the temporarily disrupted DNA base pairs to form a pseudo-catenane or bis-
intercalation complex structure [22]. Under natural conditions, DNA dynamic breathing 
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is also referred to as “partial base flipping” [23,24]. Recently, Nakatani et al. reported that 
a single-molecule ligand can, in fact, induce nucleotide base flipping [25]. Overall, the 
present study is consistent with previous investigations of the interaction between cNDIs 
and dsDNAs, which have included bis-intercalators such as bisacridine and 
bisdaunamycine [26,27]. The binding of cNDIs to dsDNAs (Fig. 3.14) is structurally 
similar to cNDI-dsDNA structures previously described by other groups [9].  
 
  
Fig. 3.2. Spectral shifts of 6.7 µM of 1 on titration with 0, 5, 10, 15, 20, 25, 30, 40 and 50 
µM Calf thymus DNA (A) (from top to bottom). Scatchard plots for the binding of 1 to 
Calf thymus DNA (B). Experiments were performed at 25°C in 10 mM MES buffer pH 
6.25 containing 100 mM NaCl and 1 mM EDTA. 
 
Table 3.1 Binding parameters of 1-3 with CT-DNA, Ploy [d(A-T)]2 and Poly [d(G-C)]2 
 1 2 3 
DNAs 10-6Kb/M-1 n 10-6Kb/M-1 n 10-6Kb/M-1 n 
CT-DNA 0.7± 0.01 4.5 0.12± 0.005 4.9 0.34±0.006 3.4 
Poly [d(A-T)]2 0.6± 0.055 3 0.10± 0.004 5 0.28±0.001 3 
Poly [d(G-C)]2 5.34± 0.6 4 0.5 ± 0.013 3.5 0.84±0.026 2.2 
Condition: 10 mM MES (pH6.25), 1 mM EDTA, and 0.1 M NaCl.  
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Fig. 3.3. UV-Vis absorption spectra of 6.7 µM 1 (A, C, E), 2 (G, I, K) or 3 (M, O, Q) in 
the absence and presence of titrant calf thymus DNA (A, G, M), Poly (dA-dT)2 (C, I, O) 
and Poly (dG-dC)2 (E, K, Q) with 0, 5, 10, 15, 20, 25, 30, 40 and 50 µM respectively. 
Binding affinities were estimated using the scatchard plot of 1 (B, D, F), 2 (H, J, L) or 3 
(N, P, R) using the titrant calf thymus DNA (B, H, N), Poly (dA-dT)2 (D, J, P) and Poly 
(dG-dC)2 (F, L, R). Experiments were performed at 25°C in 10 mM MES buffer pH 6.25 
containing 100 mM NaCl and 1 mM EDTA. 
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Table 3.2 Summary of the optical properties of free and DNA bound 1-3.  
DNAs CT-DNA Poly [d(A-T)]2 Poly [d(G-C)]2 
ligads 1 2 3 1 2 3 1 2 3 
λmax (free)/nm 383 383 383 383 383 383 383 383 383 
λmax (bound)/nm 387 386 388 387 386 387 388 385 388 
λiso/nm 395 395 393 394 396 392 392 393 391 
H/% 60 60 62 47 49 60 61 61 61 
λiso: Wavelength at the isosbestic point; H: Hypochromicity, measured by using the 
formula,H%=Absorbance at 383 nm (free) - Absorbance at 383 nm (bound)/ Absorbance 
at 383 nm (free) × 100 [28].  
 
3.3.2. Thermodynamic analysis  
The interaction between a drug and biomolecule may involve hydrophobic forces, 
electrostatic interactions, van der Waals interactions and hydrogen bonds. According to 
data on enthalpy changes (△H) and entropy changes (△S), the following model of 
interaction between a drug and a biomolecule can be concluded: (1) △H > 0 and △S > 
0, hydrophobic forces; (2) △H < 0 and △S < 0, van der Waals interactions and hydrogen 
bonds; (3) △H < 0 and △S > 0, electrostatic interactions [29]. When there is little change 
in temperature, △H can be considered constant, and its value, along with that of △S, can 
be determined from the van’t Hoff (Eq. 3.2) and Gibbs free energy (Eq. 3.3) equations. 
𝑙𝑛𝐾𝑏 = −
∆𝐻
𝑅𝑇
+
∆𝑆
𝑅
                                                    (3.2) 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆                                                     (3.3) 
R is the gas constant and Kb is the binding constant (Table 3.4) at the corresponding 
temperature. Fig. 3.5 shows the spectral shift of CT-DNA upon binding of 1. Using this 
absorption change, I measured the binding constant (Kb). The values of △H and △S were 
obtained from the slope and intercept of the linear plot (Eq. 3.2) of lnK against 1/T (Fig. 
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3.4). The value of △G was estimated from Eq. (3.3). Its negative value means that the 
binding process is spontaneous (Table 3.3). The values of △H and △S for the binding 
between 1-3 and CT-DNA are listed in Table 3.3. The negative values of △H for 3 
indicates the exothermic nature of the binding process with CT-DNA and intercalation 
may occur favorable electrostatic interaction (Fig. 3.4). I have assumed that the binding 
of non-cyclic NDI with CT-DNA shows flexibility consequently energy release and 
binding process entalpically driven. On the Other hands, the binding of 1 and 2 with CT-
DNA indicates the endothermic (Fig. 3.4). The positive enthalpy and positive entropy 
values of the interaction between 1 or 2 and CT-DNA indicate that hydrophobic forces 
played a major role in the reaction. These results are consistent with previously reported 
results for binding between CT-DNA and NDI derivatives [30]. When 1 or 2 interacts 
with CT-DNA, the driving force of the interaction clearly changes from enthalpy to 
entropy. The change in entropy is governed by the release of counterions and water from 
both DNA and the ligand, and also by changes in the local DNA structure upon ligand 
binding. These features simultaneously contribute unfavorable △H and favorable △S to 
the binding free energy and have been observed by other researchers [31,32]. Spolar et al. 
have also reported that the entropy change depends on the rigidity of the DNA-protein 
complexes [32]. Moreover, the intercalating chromophore of cNDIs consists of two 
aromatic ring systems that intercalate into the DNA duplex in a parallel arrangement that 
follows the lock and key model, making its stability entropically driven [4,32]. Binding 
between the bis-intercalator echinomycin and DNA has been shown to be entropically 
and hydrophobically driven, which is in agreement with our observations of binding 
between the newly designed cNDIs and CT-DNA [4,33]. According to thermodynamic 
data, I can state that long-chain 1 was more favorable for entropy-dependent binding than 
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short-chain 2. 
 
Table 3.3 Thermodynamic parameters of binding of 1-3 to calf thymus DNA. 
Parameters 1 2 3 
△H/kcal mol-1 7.8±1 9.2±0.84 -6.7±0.67 
△S/cal mol-1 52.8±3.3 54.4±2.8 3±2 
△G/kcal mol-1 (25 ˚C) -7.95 -7.0 -7.59 
Condition: 10 mM MES (pH6.25), 1 mM EDTA, and 0.1 M NaCl. 
 
 
Fig. 3.4. Plots of lnK (the observed equilibrium constants) vs 1/T under the binding of 1-
3 to calf thymus DNA. 
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Table 3.4 Binding constants of 1-3 interacting with calf thymus DNA at different 
temperature. 
Temperature/°C 
10-5K/M-1 
1 2 3 
20.0 5.9 (±0.24) 1.2 (±0.40) 4.5 (±0.12) 
22.5 6.5 (±0.25) 1.3 (±0.40) 4.4 (±0.12) 
25.0 7.0 (±0.23) 1.4 (±0.70) 3.8 (±0.11) 
27.5 7.7 (±0.23) 1.5 (±0.12) 3.7 (±0.07) 
30.0 7.9 (±0.50) 1.8 (±0.05) 3.2 (±0.20) 
32.5 11 (±1.0) 2.0 (±0.18) 3.0 (±0.15) 
35.0 11 (±1.5) 2.6 (±0.10) 2.5 (±0.20) 
Condition: 10 mM MES (pH6.25), 1 mM EDTA, and 0.1 M NaCl. 
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Fig. 3.5. UV-Vis absorption spectra of 6.7 µM 1 with the varied amount of calf thymus 
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DNA. Experiments were performed at 20°C (A), 22.5°C (B), 25°C (C), 27.5°C (D), 30°C 
(E), 32.5°C (F), and 35°C (G) in 10 mM MES buffer pH 6.25 containing 100 mM NaCl 
and 1 mM EDTA. 
 
3.3.3. Salt effect analysis 
The entropic nature of the reaction can be related to the significant role of 
hydrophobic interactions in the binding process. Thus the electrostatic effect is almost 
entirely enthalpic [29,34]. In our study, Electrostatic interaction is less important for 
cNDIs binding to DNA because of favorable entropy. The binding constant of cNDIs to 
DNA entirely depends on salt concentration even through cNDIs is neutral. Reports in 
the past have shown that a very high concentration of NaCl would hinder small molecules 
from binding with DNA [35]. Our results show that the binding parameters decreased 
with a gradual increase in NaCl concentration (Table 3.6). According to counterion 
condensation theory (Eq. 3.4) is a measure of the number of sodium ions released from 
DNA per bound ligand. Due to the lengthening of the DNA helix and unwinding DNA 
upon intercalation, increasing the phosphate gaps along the helix axis [18,31,36]. 
Consequently, releasing condensed counterions because of the charge density of the 
duplex decreases and providing an entropically favorable contribution to the binding free 
energy. Releasing counterions explains the dramatic salt dependencies of DNA-cNDIs 
complexes. High salt destabilizes DNA- cNDIs complexes. There is a large entropic gain 
from counterion release, if the salt concentration in solution is low and the cNDIs binds 
tightly to the DNA. The entropic gain from counterion release is small, if the salt 
concentration in solution is high and the cNDIs binds weakly. I observed that an increased 
salt concentration hindered the binding of 1 more significantly than that of 2. At pH 6.25, 
the net charge would have been different because 1 possesses four nitrogen atoms in the 
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linker whereas 2 possesses only two. Moreover, at low ionic strength, a cNDI molecule 
binds to DNA with a large number of ion pairs, consequently increasing the free energy 
association through the release of a large fraction of counterions; this effect would be 
dramatically reduced at high ionic strength [37]. According to the polyelectrolyte theory 
[38], I plotted log K against –log [Na+] in Fig. 3.6, and the slope was given by Eq. 3.4. 
δ log𝐾𝑜𝑏𝑠
δ log[𝑁𝑎+]
= −𝑚𝛹                                     (3.4) 
m is the charge on the ligand and Ψ is the proportion of counterions associated 
with each DNA phosphate group, normally Ψ is 0.88 for classical intercalator with 
double-stranded B-type DNA [3,34]. However, it is known that Ψ for dicationic threading 
intercalators show 0.6 – 0.8 [16]. The data in Table 3.5 show slopes of 0.72, 0.74 and 0.83 
for 1, 2, and 3, respectively. This result suggested that these dicationic cNDI derivatives 
behave as threading intercalator and form catenane complex with double stranded DNA. 
 
Table 3.5 Salt effects of 1-3 in the binding affinity. 
cNDI derivatives 1 2 3 
δ(logKabs)/ δ(log[Na+]) 0.72 0.74 0.83 
Condition: 10 mM MES (pH6.25), 1 mM EDTA, and 0.05-0. 125 M NaCl. 
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Fig. 3.6. Plots of logK (the observed equilibrium constants), versus –log [Na+] under the 
binding of 1-3 to calf thymus DNA. 
 
Table 3.6 Binding constants of 1-3 interacting with calf thymus DNA at different salt 
concentration. 
[NaCl]/M 
10-5K/M-1 
1 2 3 
0.05 9.56 1.3 - 
0.075 7.94 1.0 - 
0.1 7.29 1.3 1.30 
0.125 5.50 0.7 0.95 
0.15 4.15 0.56 0.56 
Condition: 10 mM MES (pH6.25), 1 mM EDTA, and 0.05-0.15 M NaCl. 
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3.3.4. Stopped flow kinetic analysis 
As suggested in our group previous report [12], 1 showed a much slower 
dissociation constant in its interaction with GC than 3. In the present report, I have 
discussed in detail the association and dissociation kinetics of 1–3. 
 
Association: Typical examples of the association kinetic traces of the interactions 
of CT-DNA, Poly[d (A-T)]2, and Poly[d(G-C)]2 with 1–3 are shown in Figs. 3.7A, 3.9A 
and 3.10. All data were analyzed by two-exponential ﬁtting, and the results are 
summarized in Table 3.7. The highest absorption by the DNA duplex-ligand complex 
occurred at 383 nm (Fig. 3.9A). Association constant (ka) was determined by the apparent 
rate constant (kapp) against DNA concentration (Fig. 3.8). Absorption decreased 
dramatically and underwent a slight bathochromic shift. This phenomenon has previously 
been observed for interactions between other naphthalene diimide derivatives and 
dsDNAs [16]. Association rate constants for 1–3 increased in the following order: 
Poly[d(A-T)]2, CT-DNA, Poly[d(G-C)]2. The association process of the interaction of 1 
with poly[d(A-T)]2 was about two and five times higher than that of 3 and 2, respectively. 
The association kinetics of 1-3 with poly[d(G-C)]2 were almost two times slower than 
with poly[d(A-T)2, implying that transient breathing of the double helix influences the 
rate of association. Previous reports on naphthalene diimides derivatives as tri-
intercalators have shown similar association constant trends [6]. Indeed, a study of the 
kinetics of the threading intercalator anthracyne also exhibited a similar association trend 
that may be related to a rate-determining DNA breathing step [39]. In addition, the 
association rate constant may depend on the cyclic character and the rigidity of the ligand 
molecule. Thus, the side chains of the ligand molecule can have large effects on DNA 
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interaction kinetics. Complex formation can be slowed by the disruption of a higher 
number of adjacent base pairs when two intercalation sites open in the double helix. 
 
Dissociation: A typical example of the SDS-driven dissociation kinetic traces of 
interactions between CT-DNA, Poly[d(A-T)]2, or Poly[d(G-C)]2 and 1–3 is shown in Figs. 
3.7B, 3.9B and 3.10. All data were analyzed by two-exponential ﬁtting, and the results 
are summarized in Table 3.7. The highest absorption by the DNA duplex-ligand complex 
occurred at 383 nm (Fig. 3.9B). Absorption decreased dramatically and underwent a 
slight bathochromic shift. This phenomenon has previously been observed for 
interactions between other naphthalene diimide derivatives and dsDNAs [16]. 
Dissociation rate constants for 1–3 increased in the following order: Poly[d(G-C)]2, CT-
DNA, Poly[d(A-T)]2. It is worth mentioning the very slow dissociation of 1 from the GC-
rich complex, which was 100 times slower than that of 3 and 330 times slower than that 
of 2. This is due to the strong binding constant of the interaction between cNDIs and GC-
rich dsDNA (Table 3.1) because of the rigidity of the complex, as previously discussed. 
Many heterocyclic or highly polarizable intercalators exhibit a binding preference for GC 
base pairs with a larger asymmetric charge distribution. Although the cNDIs are 
symmetric, they still have significant partial atomic charges on the heterocyclic rings, and 
the molecule in Fig. 3.1 for example, exhibits significant GC binding specificity. These 
results are similar to previously reported dissociation rate constants for interactions 
between naphthalene diimide derivatives and CT-DNA, which were lower for GC-rich 
sequences than for AT-rich sequences [6]. A study of the kinetics of the threading 
intercalator anthracyne also noted a similar dissociation trend [39]. These effects are 
related to the high binding affinity of 1 and 2 for poly[d(G-C)]2, resulting from 
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hydrophobic interactions, favorable van der Waals stacking interactions of the large 
naphthalene diimide ring system, and partial atomic charges on the heterocyclic rings that 
can provide favorable coulombic interactions, particularly with GC base pairs. Long-
chain 1 showed slower dissociation from dsDNA than short-chain 2. Researchers have 
already found that longer chain bis-intercalators and poly-intercalators dissociate slowly 
from DNA duplexes [6]. 
 
Table 3.7 Kinetic parameters for binding of 1-3 to calf thymus DNA (CT-DNA), poly 
[d(A-T)]2, and poly [(G-C)]2. 
 
DNAs 
1 2 3 
10-5ka/M-1s-1 kd/s-1 10-5ka/M-1s-1 kd/s-1 10-5ka/M-1s-1 kd/s-1 
Calf thymus DNA 0.57±0.03 0.1 1.2±0.11 1.1 1.24±0.14 1.1 
poly [d(A-T)]2 1.2±0.11 0.15 0.32±0.08 4.2 2.6±0.35 2.6 
poly [d(G-C)]2 0.34±0.045 0.003 0.26±0.058 1.0 0.84±0.1 0.3 
Condition: 10 mM MES (pH6.25), 1 mM EDTA, 0.1 M NaCl. 
 
  
Fig. 3.7. Stopped-ﬂow kinetic traces for the association (A) and the SDS-driven 
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dissociation (B) for a complex of 1 with calf thymus DNA. The smooth line represents 
the two-exponential ﬁt to the data. A residual plot for the ﬁt showed under the 
experimental plot. The experiments were conducted at 25 °C in 10 mM MES buffer and 
1mM EDTA with 0.1 M NaCl and the concentration of 1 to DNA base pair ratio of 1:10. 
 
 
Fig. 3.8. Plot of the apparent rate constants (kapp) against DNA concentrations for the 
determination of association rate constant (ka).  
 
 
 
Fig. 3.9. Stopped-ﬂow kinetic traces of absorption spectra at 383 nm for (A) association 
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(B) SDS-driven dissociation for a complex of 1 with calf thymus DNA. The experimental 
condition was under the same condition described in Fig. 3.7. 
 
 
 
 
  
 
 
  
 
Fig. 3.10. Stopped-flow kinetics traces for association of 1 (A, B, C), 2 (D, E, F) and 3 
(G,H,I) from calf thymus DNA (A, D, G), from Poly [d(A-T)]2 (B, E, H) and from Poly 
[d(G-C)]2 (C, F, I). The experiments were conducted in 10 mM MES buffer and 1 mM 
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EDTA (pH 6.25) containing 100 mM NaCl. [Ligand]/ [DNA/bp] =1:10. 
 
 
 
 
  
 
 
 
 
 
Fig. 3.11. Stopped-flow kinetics traces for SDS driven dissociation of 1 (A, B, C), 2 (D, 
E, F) and 3 (G, H, I) from calf thymus DNA (A, D, G), from Poly [d(A-T)]2 (B, E, H) and 
from Poly [d(G-C)]2 (C, F, I). The experiments were conducted in 10 mM MES buffer pH 
6.25 containing 100 mM NaCl and 1 mM EDTA. [Ligand]/ [DNA/bp] =1:10 
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3.3.5. Topoisomerase I assay 
Topoisomerase-based gel assays have been widely used to evaluate compounds 
for their ability to intercalate DNA [40]. The ability of NDI derivatives to cause re-
supercoiling of plasmid DNA has been frequently reported [12,13]. The topoisomerase I 
assay exploits the ability of the topoisomerase I enzyme to relax supercoiled DNA (e.g., 
pUC19-plasmid DNA). In the presence of an intercalator, the enzyme will convert the 
relaxed DNA into a supercoiled state by unwinding the DNA structure. Previously, our 
group reported that 1 and 3 are DNA intercalators [12,13]. In the present study, plasmid 
DNA was treated with increasing concentrations of 2 in the presence of topoisomerase I. 
Complete re-supercoiling of the plasmid DNA upon interaction with 2 was readily 
observed, indicating its identity as a DNA intercalator (Fig. 3.12). Remarkably, 
Compound 1 elicited re-supercoiling more effectively than 2. Compound 1 re-supercoiled 
DNA completely at a concentration of ca. 2 µM, whereas the concentration of 2 required 
to show a similar effect exceeded ca. 10 µM. These results are in agreement with the 
higher binding affinity of 1 for DNA duplexes. 
 
 
Fig. 3.12. Topoisomerase I assay for pUC19 treated with 5.0 U of enzyme. Following 
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incubation at various concentrations of 2 (2.0, 5.0, 10, 20, 30, 40, 50 μM from left to 
right) was added and the mixture incubated further. After work-up, DNA was 
electrophoresed Lanes M and Topo I represent 1 kb size markers and pUC19 respectively. 
OC and CCC refer to open circle and the covalent closed circle respectively.  
 
3.3.6. Circular dichroism (CD) studies 
Intrinsic and induced CD spectroscopy was used to further elucidate the 
conformational aspects of the interaction between cNDIs and CT-DNA. The 
characteristic CD spectrum of right-handed B-form DNA in the 200–300 nm region can 
provide information indicating specific structural changes in DNA upon interaction with 
ligands. Previously, our group reported that 1 and 3 induce a negative CD band (in the 
340–440 nm region) upon interaction with CT-DNA, Poly [d(A-T)]2, or Poly [d(G-C)]2, 
indicating an intercalative binding mode [12]. Compounds 1 and 3 also showed a dramatic 
change in the CD spectrum in the region of 220-320 nm, indicating that the ligands affect 
duplex stability and conformation [12]. In the present study, I used CD spectroscopy to 
investigate the interaction between 2 and CT-DNA. As depicted in the CD spectrum (Fig. 
3.13A), I observed a negative peak around 245 nm for free CT-DNA, due to helicity, and 
a positive peak around 276 nm, due to base stacking. After the addition of 2, the positive 
and negative CD bands increased rapidly without any shift in the band position. I also 
observed a small negative band around the 320–400 nm region (Fig. 3.13B). These bands 
indicated that binding of CT-DNA had reached the saturation point. In light of previous 
reports [41], the negative CD band associated with 2-CT-DNA complexes may indicate 
that 1 and 2 intercalate with the long axis of the chromophore oriented parallel or 
perpendicular to the long axis of the DNA base pair [11]. Compound 1 induced higher 
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CD spectra than 2 and 3, in agreement with its stronger binding to DNA duplexes DNA 
than that of 2. 
 
  
Fig. 3.13. (A) CD spectra of 100 µM DNA samples titrated with 2 (0, 5,10,15, 20, 25, 30, 
40 and μM from bottom to top) at 25°C in 10 mM MES buffer and 1 mM EDTA (pH 
6.25) containing 100 mM NaCl. (B) Induced CD spectra at wavelength region 320-400 
nm. 
 
  
Fig. 3.14. Computer modeling of the complex of 1 (A) and 2 (A) with dsDNAs. 
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3.3.7. Computer modeling 
Double stranded DNA was created with the Create Sequence of MOE software. 
Base pairs of binding site were expanded to have 3.4 Å space with slightly unwinding. 
After preparing the docking complex of cyclic naphthalene diimide with the DNA, the 
complex was minimized with a tether of nucleic bases. Computer modeling of the 
structures of the 1- and 2-dsDNA complexes is shown in Fig. 3.14. Previously, our group 
reported the binding mode of 1 with dsDNA. Here we propose a similar binding mode, 
with bis-threading intercalation or formation of a pseudo-catenate complex between 1 or 
2 and dsDNA, which is consistent with a model previously published by Iverson et al. [9]. 
Computer modeling suggests that the 2-dsDNA complex has a steric strain effect, due to 
the shorter linker chain. 
 
3.4. Conclusions 
I have developed a new type of bis-intercalator, 2, which was synthesized by the 
cyclization of naphthalene diimide (NDI). Previously, our group reported in our 
investigation of the interaction between 1 and dsDNA [12]. Here I have compared of the 
interaction between 1 and dsDNA with that of 2 and dsDNA. The result of interaction 
studies of 1–3 with dsDNAs follows the order 1> 2 > 3, which suggests that the long-
chain 1 has higher dsDNA binding selectivity and binds dsDNA with more favorable 
thermodynamics and kinetics than 2. UV-Vis analysis showed high binding affinity of 1 
to dsDNA in the range of 6 × 105–5.3 × 106 M-1 (approximately 10 times higher than that 
of 2), with bis-intercalation of four base pairs per ligand molecule. Thermodynamic 
studies of 1 and 2 indicated that entropy-dependent hydrophobic interactions play a major 
role in their interaction with dsDNA. Compound 1 showed more entropically favorable 
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interactions with dsDNA than 2. Kinetics studies of 1 and 2 indicated that 1 dissociate 
from GC base pairs more slowly than 2 because of its unique, pseudo-catenane, bis-
intercalative binding with stairs of dsDNA. Induced CD spectra and a topoisomerase I 
unwinding assay further supported the more favorable bis-intercalation binding of 1 over 
that of 2. 
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A Selective G-Quadruplex DNA-Stabilizing 
Ligand Based on a Cyclic Naphthalene Diimide 
Derivative 
Contents of this chapter have been published in the Molecules Journal (M.M. Islam, S. 
Fujii, S. Sato, T. Okauchi, S. Takenaka, Molecules, 20 (2015) 10963-10979). The 
materials of the chapter have been reproduced with the permission of the Molecules 
Journal [1]. 
 
4.1. Introduction 
Guanine-rich DNA sequences which mainly originate in important regions of the 
oncogene promoters, telomere, mRNA, ribosomal DNA (rDNA), and thrombin-binding 
aptamer (TBA) can form G-quadruplex structures [2-4]. G-quadruplex DNAs, formed at 
the telomeric end, can inhibit telomere elongation by telomerase, which are activated in 
80%–85% cancer cells, leading to inhibition of telomerase activity [2,5]. G-quadruplex 
DNAs is known to be formed at promoter regions of the human oncogene that can regulate 
gene expression at the transcriptional level [4]. DNA aptamers bind to thrombin and 
inhibit thrombin-catalyzed fibrin, resulting in blood clotting [3]. Thus, guanine-rich 
sequences have become a very promising target for the development of new anticancer 
drugs and therapeutic applications, which was attracted a lot of research interest during 
the last few decades and a few of the resulting compounds have entered into preclinical 
or clinical trials [4]. 
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It has been reported that guanine-rich oligonucleotides could form G-
quadruplexes via Hoogsteen hydrogen bonding among four guanine bases arranged in a 
square planar configuration [5]. G-quadruplex DNA shows diverse structural 
polymorphism; G-quadruplex DNA can be either parallel or antiparallel, even both 
conformations (termed hybrid) in some cases [6,7]. This G-quadruplex DNA can fold as 
a mixture of several different quadruplex forms depending on DNA sequence and 
extrinsic cation which offers a platform to induce and stabilize the quadruplexes by using 
small organic molecules [6,7]. This common structural feature poses challenges for the 
design of ligands with considerable selectivity toward one type of quadruplex over other 
G-quadruplex structures [7]. 
 
Small molecules that stabilize the G-rich single-strand DNA overhang into G-
quadruplex can be considered as potential anticancer and therapeutic agents [4]. A 
number of G-quadruplex-binding small molecules have been reported in the last few 
decades [4,8,9]. Several diverse structural ligands, including telomestain, oxazole, 
cationic TMPyP4, anthraquinone, perylene, acridine, and ethidium derivatives have been 
investigated to evaluate their ability to interact with G-quadruplex DNA and observe their 
biological functions [4,8,9]. There are a number of macrocyclic structures that have been 
developed in the last few years as G-quadruplexes DNA binding ligands such as BQQ1, 
telomestain, oxazole, porphyrin, etc. [10], which is a well-established technique to 
improve the development of G-quadruplex DNA selective drugs. A common feature of 
these G-quadruplex-binding molecules is the presence of an extended aromatic ring 
system that allows binding through π-π overlap of terminal G-tetrads [6,10]. Large flat 
aromatic planar molecules stack on G-tetrads and show high binding selectivity [7]. Non-
planar molecules that stack with G-quadruplexes are very rare and bindings are moderate 
[7]. Some of these G-quadruplex-binders include porphyrin derivatives, oxazoles, 
perylene derivatives and similar systems [11] that have fused π-ring systems within the 
molecule and showed various binding selectivity with the G-quadruplexes’ DNA 
structure. Nowadays, the researchers are focusing on developing G-quadruplex DNA 
structure-specific and selective binding ligands [7,10] which are important for drug 
development, cancer research and therapeutic application studies. 
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Naphthalene diimides (NDIs) are very potent G-quadruplex-binding ligands with 
high cellular toxicity, which is able to effectively stabilize the terminal G-quartet of a G-
quadruplex by stacking interactions [12,13]. Over the last few years a number of NDI-
based compounds have been developed in part by exploiting the available NDI-G-
quadruplexes structures [14-22]. In our previous studies, our group has already reported 
interaction studies of some cyclic NDI derivatives and h-telo 22 G-quadruplex DNA, 
which can inhibit telomerase activity at low concentration [11,23]. In our present work, I 
synthesized new compound 2 by cyclization with the linker chain of a tertiary amino 
group and amide group through benzene to compare the binding selectivity with our 
previously reported compound 1 [11] (Figure 4.1). Compound 2 is expected to show 
reduced binding to dsDNA and increased binding affinity for G-quadruplexes DNA 
because of its shorter linker substituents. I have also sought to compare the binding 
selectivity among the various structures of G-quadruplex DNA. I have characterized the 
binding selectivity and stability of 2 to G-quadruplexes’ DNA present in the promoter 
region (c-myc and c-kit), thrombin binding aptamer (TBA) and human telomeric region (a-
core and a-coreTT) by UV-Vis spectroscopy, circular dichroism (CD) spectroscopy, 
thermal melting studies, TRAP assay and FRET-melting assay [24] experiments. 
 
 
Fig. 4.1. Chemical structures of 1, 2 and 3 (1 taken from [11]). 
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4.2. Experimental Procedure 
 
4.2.1. Materials 
The seven G-rich oligonucleotides: a-core (5′-AGGG(TTAGGG)3-3′), a-coreTT 
(5′-AGGG (TTAGGG)3TT-3′), TBA (5′-GGTTGGTGTGGTTGG-3′), c-kit (5′-
AGGGAGGGCGCTGGGAG GAGGAGGG-3′), c-myc (5′- 
TGAGGGTGGGGAGGGTGGGGAA-3′) and dsDNA composed of two complementary 
strands: (5′-GGGAGGTTTCGC-3′) and (5′-GCGAAACCTCCC-3′) were purchased 
from Genenet Co. (Fukuoka, Japan) and used without further purification. The following 
extinction coefficients were used for quantification of nucleic acid solutions (unit of ε 
was M−1 cm−1): 114,000 for 5′-GGGAGGTTTCGC-3′; 108,600 for 5′-
GCGAAACCTCCC-3′; 228,500 for a-core (5′-AGGG (TTAGGG)3-3′); 245,100 for a-
coreTT (5′-AGGG(TTAGGG)3TT-3′); 143,300 for TBA (5′-GGTTG GTGTGGTTGG-
3′); 260,100 for c-kit (5′-AGGGAGGGCGCTGGGAGGAGGAGGG-3′); 229,900 for c-
myc (5′-TGAGGGTGGGGAGGGTGGGGAA-3′). Before use, oligonucleotide solutions 
in 50 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl or KCl were heated to 95 
°C and annealed by slowly cooling to room temperature. Guanine-rich telomere 
oligonucleotide sequence (5′-d-GGGTTAGGGTTAGGGTTAGGG3′), dual label with 
FAM (fluorescent donor) and TAMRA (fluorescent acceptor) at the 5′ and 3′ end, called 
‘F21T’, respectively, were purchased from Sigma-Aldrich (St. Louis, MO, USA). The 
synthesis procedure of 2 was described in detail in a previous article [25]. Compound 3 
was synthesized as described previously [26]. The 2.0 M KCl, and 5.0 M NaCl aqueous 
solutions were obtained from Life Technologies (Carlsbad, CA, USA). 1.0 M Tris-HCl 
(pH 7.4) buffer was obtained from Sigma-Aldrich. GoTaq Hot Start polymerase was 
purchased from Promega (Madison, WI, USA). TRAPese kit was obtained from EMD 
Millipore (Billerica, MA, USA). 
 
4.2.2. UV-Vis Titration Experiments 
Absorption spectra were measured on a U-3310 spectrophotometer (Hitachi, 
Tokyo, Japan) with a 1 cm path-length quartz cell and were recorded in the 200–600 nm 
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range at 25 °C. UV-Vis absorption titrations were carried out by the stepwise addition of 
200 μM/strand of G-quadruplexes DNA or dsDNA solution to a UV-cell containing 5.0 
μM solutions of 2 or 3. The measurements were performed in a 50 mM Tris-HCl buffer 
(pH 7.4) containing 100 mM NaCl or KCl. Binding data obtained from 
spectrophotometric titration of increasing concentrations of drug to a fixed concentration 
of DNA was cast into the form of a Scatchard plot of ν/C against ν. The Scatchard plot 
was analyzed by the Scatchard equation: ν/C = K(n–ν) [27], where ν is the stoichiometry 
(the number of ligand molecules bound per moles of base pair), C is the free ligand 
concentration, K is the observed binding constant, and n is the number of base pairs 
excluded by the binding of a single ligand molecule. For duplex oligonucleotides 
saturation of binding curves was not achieved, so K values were estimated using Benesi-
Hildebrand method 1/ΔAbs = 1/(lΔε [ligand]) + 1/(nKlΔε [ligand]) × (1/DNA) [28] with 
the assumption that the ligand/oligonucleotide complex with 1:1 stoichiometry is formed 
(Table 4.1), where Δε is a molar absorptivity change of ligand and l is 1 cm. Scatchard 
plots were prepared using absorption changes at the specific wavelength 383 nm upon the 
addition of various concentrations of dsDNA. Scatchard plots were prepared using the 
data in a range of approximately 30%–80% bound region of 2 and dsDNA. The binding 
data were analyzed with KaleidaGraph software, using the Levenberg-Marquardt 
algorithm to determine parameters Kb and n. 
 
4.2.3. Circular Dichroism (CD) Measurements 
Various concentrations (5.0 to 50 μM) of 2 or 3 were added to 1.5 μM/base pair 
G-quadruplexes DNA in a 50 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl or 
KCl at 25 °C, and CD spectra taken at a scan rate 50 nm/min on a J-820 
spectropolarimeter (Jasco, Tokyo, Japan). Other conditions were: response 2 s, data 
interval 0.1 nm, sensitivity 100 mdeg, band width 2 nm, and scan number 4 times. 
  
4.2.4. Thermal Melting Experiments 
Melting curves of G-quadruplexes DNA or dsDNA were measured on a Hitachi 3300 
spectrophotometer (heating rate of 0.5 °C/min to 90 °C) or Jasco J-820 spectrophotometer 
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(response, 100 mdeg; response, 8 s; data collecting interval, 0.5 °C; bandwidth, 2 nm) 
equipped with a temperature controller, respectively. The melting curves based on 
circular dichroism (CD) at 290 nm of a-core, a-core TT, and TBA, 262 nm of c-kit and c-
myc or 260 nm of dsDNA were measured in 50 mM Tris-HCl (pH 7.4) containing 100 
mM NaCl or KCl (for c-kit 20 mM KCl and for c-myc 5 mM KCl). A mixture of 1.5 μM 
a-core, a-core TT, TBA, c-kit, c-myc, dsDNA and 3.0 μM of 2 or 3 was placed in a cell 
of 1 cm in light path length (total 3 mL). Ligand-DNA ratio was set at 2:1. 
 
4.2.5. TRAP Assay Experiments 
Telomeric repeat amplification protocol (TRAP) assay was performed using 
published procedure [11,23]. TRAPeze Telomerase Detection Kit from EMD Millipore 
was used. Briefly, TS forward primer was elongated by telomerase in TRAP buffer (20 
mM Tris-HCl pH 8.3, 1.5 mM MgCl2, 63 mM KCl, 0.05% Tween 20, 1.0 mM EGTA) 
containing 0.05 mM dNTPs, 0.4 μM TS primer, 0.4 μM primer Mixed (RP primer, K1 
primer, TSK1 primer) and 2.0 units of GoTaq Hot Start polymerase. The mixture was 
added to freshly prepared 2 solution from 0.1 to 4.0 μM (0, 0.1, 0.25, 0.5, 0.75, 1.0, 2.0, 
3.0, 4.0 μM) and a positive control containing no ligand. Firstly, the elongation step was 
carried out for 60 min at 30 °C and it was followed by 5 min incubation at 95 °C. 
Secondly, 35 cycles of PCR were performed (94 °C, 30 s; 62 °C, 1 min; 72 °C, 1 min). 
Telomerase extension products were analyzed on a denaturing 12.5% polyacrylamide 
vertical gel prepared in 5 × TBE buffer (89 mM Tris base, 89 mM borate, and 1 mM 
EDTA, pH 8.0). The electrophoresis were run in 0.7 × TBE buffer for 2 h at 200 V. After 
electrophoresis gel was stained in 1 × GelStar Nucleic Acid Stain (Takara Bio, Shiga, 
Japan) in 1× TBE buffer for 30 min and photographed. 
 
4.2.6. FRET-Melting Assay 
Fluorescence-based melting competition assays was performed using a previously 
published procedure [24]. In more recent experiments, a real-time PCR apparatus 
(MX3000P, Stratagene, La Jolla, CA, USA; or Sigma-Aldrich SYBR Green or DNA 
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engine Opticon, MJ Research, Waltham, MA, USA) is used, allowing the simultaneous 
recording of 32–96 independent samples as first proposed by S. Neidle and co-workers 
[24]. The protocol used for our experiments is the following: a first step of equilibration 
at the lowest temperature (5 min at 25 °C) and a stepwise increase of 1 °C every minute 
for 72 cycles to reach 95 °C. The buffer 100 mM Tris-HCl (pH 7.4) containing 150 mM 
NaCl or KCl and 0.4 μM 2 was used for all experiments. The thermal denaturation profile 
of the oligonucleotide F21T (0.2 μM) and G-quadruplexes DNA (a-coreTT, TBA, c-kit 
and c-myc) (1.0 or 3.0 μM) were measured in the presence of 2 (0.4 μM). The ratio of F21T 
and G-quadruplexes DNA was used 1:5 or 1:15 at 0.4 μM 2. Fluorescence-based melting 
assays competition measurements were performed with F21T dual label with FAM 
(fluorescent donor) and TAMRA (fluorescent acceptor) at the 5′ and 3′ end from Sigma-
Aldrich at a heating rate of 1 °C/min. The recording is performed after 1 min stabilization. 
Typically three replicate experiments were performed, and average values are reported. 
Finally, the amount of ligand bound to the DNA was quantified by fluorescence after the 
digestion of the oligonucleotide (λex and λem were set to 490 and 520 nm for 
oligonucleotides, respectively). 
 
4.2.7. Computer Modeling 
Molecular modeling of these complexes was constructed by MOE 2011.10 
(http://www.chemcomp.com/). Compound 2 was placed on the binding site of mixed 
hybrid types G-quadruplex DNA (a-core) and energy minimization of these complexes 
was carried out. The molecular dynamics calculation of these mineralized complexes was 
further carried out until 2 was located in the binding site as stable condition. Finally, 
energy minimization of the complexes was obtained as shown in Fig. 4.11. These 
calculations were used the force field of MMFF94x. 
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4.3. Results and Discussion 
 
4.3.1. UV-Vis Absorption Titration 
To obtain the binding constant and the number of bound molecules for the 
interaction of 2 and 3 with different DNA forms such as human telomere (a-core and a-
coreTT) [5,29,30], promoter region (c-kit and c-myc) [31-33] and thrombin-binding 
aptamer (TBA) [34,35] their absorption spectra were investigated (Fig. 4.3). Fig. 4.2A 
shows a representative spectrophotometric titration of 2 with human telomeric G-
quadruplex DNA (a-core) in K+ ion. It shows a maximum absorption at 384 nm. Addition 
of increasing amounts of G-quadruplex DNAs to 2 resulted in large hypochromicities 
(45%–60%) and a noticeable small red shift (3–8 nm) was observed. These spectral 
features are suggestive of end-staking binding rather than groove binding (Fig. 4.2). I 
observed isosbestic points at 392 nm and 395 nm of 2 for G-quadruplex DNAs and duplex 
DNA, respectively. The presence of isosbestic points indicated the equilibrium between 
the bound and free ligand. For comparison, I also investigated the interaction of 2 with 
dsDNA. Upon the addition of increasing amounts of dsDNA to 2, smaller hypocromic 
shifts (25%–30%) and red shifts (2–4 nm) were observed than for G-quadruplexes DNA, 
suggesting this compound is not a good dsDNA binder (Fig. 4.2B). The Scatchard plot 
representing the binding between 2 and a-core (KCl) is presented in Fig. 4.2C. The 
Scatchard plot was analyzed by the McGhee-von Hippel Scatchard equation [27]. The 
solid line in Fig. 4.2C represents the best fit of the experimental value to the McGhee-
von Hippel equation. For dsDNA saturation of binding curves was not achieved; 
therefore, estimation of K values using the Scatchard equation was impossible. However, 
nK values were estimated using the Benesi-Hildebrand method [28]. Ligand binding 
affinity to dsDNA does not depend on the nature of the metal cation, such as sodium and 
potassium ions. In the presence of sodium and potassium ions compound 3 binds to 
dsDNA approximately 20 times stronger than 2. 
Page 92 of 117 
 
 
Fig. 4.2. Spectral shifts of 5 μM 2 on titration with 0, 1.4, 2.9, 4.4, 5.8, 8.7 and 14 
μM a-core (A) or 0, 2.0, 5.0, 10, 20, 30, and 40 μM dsDNA (B) in 50 mM Tris-HCl 
(pH7.4) and 100 mM KCl. Scatchard plots for binding of 2 to a-core (C) and 
Benesi-Hildebrand plot for binding of 2 to dsDNA (D). 
The intrinsic binding constants (K) of 2 and 3 to G-quadruplexes DNA and 
dsDNA are summarized in Table 4.1. Our group has already reported that 1 carrying a 
benzene moiety as longer linker chain showed higher binding affinity to either G-
quadruplexes DNA or dsDNA than 3 [11]. In our present study, our group also found 
similar binding constant trends for G-quadruplexes DNA in the range of 106–107 M−1 
with n = 2, which shows almost five times higher binding affinity of 2 compared with the 
non-cyclic derivative 3. Comparing with 1 [11], 2 showed almost three times higher 
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binding affinity to a-core and 70 times weaker binding to dsDNA. Compound 2 showed 
approximately 200 higher selectivity to G-quadruplexes DNA than the previously reported 
1 [11]. The comparison suggests that the shorter cyclic linker chain 2 showed higher 
specific binding to G-quadruplex DNAs than the previously reported longer linker chain 
compound 1 [11]. 
 
Table 4.1 Binding parameters and melting temperatures of 2 and 3 with a-core, a-
core TT, c-kit, c-myc, TBA and dsDNA. 
DNAs 
2 3 Tm/°C  ∆Tm/°C 
10−6 K/M−1 n 10−6 K/M−1 n DNAs 2 3 
a-core (K+) 10 ± 0.5 a 1.5 1.6 ± 0.2 a 1.4 69 c 15 5 
a-core (Na+) 1.0 ± 0.04 a 2.2 0.73 ± 0.09 a 1.0 57 c - 1 
a-core TT (K+) 6.1 ± 0.4 a 1.8 1.9 ± 0.3 a 1.3 63.5 c 18 - 
TBA (K+) 3.5 ± 0.2 a 1.4 0.49 ± 0.04 a 1.1 50.5 c 11 - 
c-kit (K+) 1.9 ± 0.18 a 1.4 0.74 ± 0.05 a 1.7 54 d 11 - 
c-myc (K+) 4.0 ± 0.3 a 1.7 1.5 ± 0.2 a 1.6 70 e 15 - 
dsDNA (K+) 0.037 b - 0.60 ± 0.04 a 2.8 49 c 0.3 12 
dsDNA (Na+) 0.037 b - 0.60 ± 0.08 a 3.0 49 c 0.3 12 
Condition: Binding constant (K): 50 mM Tris-HCl (pH 7.4) and 100 mM NaCl or KCl; a: 
Scatchard analysis (K); b: Bensi-Hildebrand analysis (nK); Thermal melting: 
[ligand]:[DNA] = 2:1, 50 mM Tris-HCl (pH 7.4); c: 100 mM NaCl or KCl; d: 20 mM KCl; 
e: 5.0 mM KCl. 
 
In comparison with our previous report [11], the linker chain of 2 and 1 may play 
an important role in the binding with G-quadruplexes DNA over dsDNA. The amide 
chains of 2 and 1 might be more effective in reducing binding with dsDNA because of 
the NDI moiety site blocks the aliphatic chain from intercalating in the benzene part. 
Moreover, the benzene part itself also prevents binding of 2 and 1 from threading 
intercalations with dsDNA. However, as our group has reported earlier [25], 2 and 1 
showed affinity to calf thymus DNA (CT-DNA), Poly[d(A-T)]2 and Poly[d(G-C)]2 due to 
hydrophobic interactions between cyclic NDI derivatives and dsDNA. Compound 2 
showed lower binding affinity to CT-DNA, poly[d(A-T)]2 and poly[d(G-C)]2 than 1 
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perhaps because of steric reasons, whereas, according to the computer modeling, the NDI 
moiety site of cyclic NDI derivatives incorporated to end staking onto the G-quartet. I 
have observed that 2 showed higher selectivity to G-quartet than 1 because the tertiary 
amino chain in the linker chain of 2 may have more compatibility to bind specifically 
with the G-quartet plane than the piperazine linker chain of 1. 
 
In the presence of sodium ions the binding affinities of both ligands to basket-type 
tetraplex structures were much lower than G-quadruplexes in potassium solution. Our 
group already explained that this might be due to the fact that basket type a-core crosses 
its oligonucleotide chain over the G-quartet diagonally and disrupts access of 2 to the G-
quartet plane [11]. 
 
In our present study, all the G-quadruplexe DNA showed higher binding constants 
(K) with 2 than dsDNA. In potassium ion solution, 2 exhibited the highest binding affinity 
for mixed hybrid type a-core [29] with K = 1 × 107 M−1, whereas diminished the binding 
affinity to dsDNA with nK = 3.7 × 104 M−1. The binding data indicated that 2 has a 270-
fold preference for a-core over dsDNA. Table 4.1 shows the binding constants (K) are K 
= 6.1 × 106 M−1 for a-coreTT (hybrid type-2) [30], K = 1.9 × 106 M−1 for c-kit (parallel 
propeller type) [32], K = 4.0 × 106 M−1 for c-myc (parallel type) [32], K = 3.5 × 106 M−1 
for TBA (antiparallel chair type) [35] with 2, which represent a 165-, 51-, 108- and 95-
fold binding preference over dsDNA (K = 3.7 × 104 M−1), respectively. The ratio of ligand 
per dsDNA used for binding was n = 3, a reasonable result considering that a typical 
intercalator covers two base pairs upon binding to dsDNA, in addition to the expected 
relative difficulty in binding at terminal sites. The binding number of a ligand with G-
quadruplexes DNA was estimated to be n = 2, which may agree with an end-stacking 
binding of 2 to the external G-quartet planes of quadruplexes. 
 
According to the above result, new compound 2 showed G-quadruplexes DNA 
structure-specific binding. Compound 2 showed the highest affinity to a-core DNA, 
which exhibits mixed type hybrid (hybrid-1 and hybrid-2) structures in K+ [25] and 
possessed more than two drugs staking plane and binding loops. Computer modeling 
showed that 2 was stacked and bound to a mixed hybrid structure at various G-quadruplex 
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staking planes, whereas a-coreTT exhibited hybrid-2 [30] type structures which have two 
G-tetrads staking planes and two binding sites. For this reason I observed that 2 showed 
the highest affinity with a-core. TBA exhibited an antiparallel chair type [34,35] structure 
which has G-quartet staking planes and binding loops, while c-kit and c-myc exhibited 
parallel type [32] propeller structures which possess two G-quartet staking planes, but 
binding loops are unusual for 2. According to the binding data, new compound 2 was 
revealed to be a most preferable and specific binder to telomeric G-quadruplexes DNA 
than promoter regions’ G-quadruplex DNA as well as thrombin binding aptamer. The 
binding study results are consistent with thermal melting studies where a-core showed the 
highest stabilization with 2. The binding site size (n values) obtained from binding studies 
of G-quadruplexes and 2 are consistent with the Job plot analysis from CD studies (Fig. 
4.5). 
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Fig. 4.3. UV-Vis absorption spectra of 5.0 µM 2 in the absence and presence of a-
core (A), a-coreTT (C), TBA (E), c-kit (G), c-myc (I) and dsDNA (K) with 0.5, 
1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 10 and 20 µM respectively. Binding affinities were 
estimated using the scatchard plot of 2 with a-core (B), a-coreTT (D), TBA (F), c-kit 
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(H), c-myc (J) and Benesi-Hildebrand plot of 2 with dsDNA (L). Experiments were 
performed at 25°C in 50 mM Tris-HCl (pH 7.4), 100 mM KCl. 
 
4.3.2. Circular Dichroism (CD) Studies 
The CD is a powerful method to differentiate the parallel, anti-parallel, and mixed-
type secondary structure of G-quadruplex DNA. Compound 2 was interacted to 
investigate the effect of the binding mode on the conformation of the G-quadruplexes, 
which is shown in Fig. 4.4. The CD spectrum of human telomere (a-core) G-quadruplex 
DNA showed a negative peak at 240 nm, a shoulder peak at 265 nm and a positive peak at 
290 nm (Fig. 4.4A) in buffer containing 100 mM KCl, supportive of a mixed hybrid type 
(hybrid-1 and hybrid-2) G-quadruplex structure [36,37]. The small positive peak at 265 
nm was transformed increasingly into a negative peak at 260 nm together with an increase 
of the positive peak at 290 nm upon the addition of 2, suggesting the induction of a hybrid 
type structure. After addition of 2, a-core structure, conformation changed a little from a 
mixed hybrid type to hybrid-1 type [38]. In our previous study, our group reported that in 
the presence of Na+ ions, telomeric DNA exists in an antiparallel basket-type 
conformation. Upon addition of 2, this antiparallel basket-type structure was also retained 
[11]. 
 
The CD spectrum of human telomere (a-coreTT) G-quadruplex in buffer 
containing 100 mM KCl exhibits a negative peak at 240 nm, a shoulder peak at 265 nm and 
a positive peak at 290 nm (Fig. 4.4B) supportive of a hybrid-2 type G-quadruplex structure 
[36,37]. The small positive peak at 265 nm is transformed increasingly into a negative 
peak at 260 nm together with an increase of the positive peak at 290 nm upon the addition 
of 2, suggesting the induction of a hybrid type structure. After the addition of 2, a-core 
structure conformation changed a little from hybrid-2 type to hybrid-1 type [38]. 
 
In the presence of 100 mM KCl thrombin-binding aptamer (TBA, Fig. 4.4C) 
exhibited a positive peak at 290 nm, and a negative band at 250 nm, supportive of an anti-
parallel chair type G-quadruplex structure [35,39]. Upon the addition of 2, the negative 
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peak transformed increasingly into at 260 nm together with an increase of the positive 
peak at 290 nm, suggesting that the binding of 2 apparently does not disturb the structure 
of TBA, which is consistent with previous reports [39]. 
 
Fig. 4.4. CD spectra of 1.5 μM of a-core (A); a-coreTT (B); TBA (C); c-kit (D); c-myc 
(E) in 50 mM Tris-HCl (pH 7.4), 100 mM KCl in addition of 2 (0, 0.38, 0.75, 0.80, 2.25, 
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and 3.00 μM) at 25 °C.  
 
Both c-myc and c-kit G-quadruplex (Fig. 4.4D,E) exist in the presence of K+ ions 
as a parallel structure, which has a characteristic positive peak centered around 262 nm, 
a negative peak at 241 nm and a small shoulder peak at 290 nm [40,41]. After the addition 
of 2 to c-myc and c-kit G-quadruplex, a decrease of the CD peaks at 241 nm and 262 nm 
was observed, with no other significant change in the spectrum and the parallel structure 
was not changed, which suggests ligand-dependent disruption of staking of G-quadruplex 
DNA. Upon the addition of 2, the c-kit structure shoulder peak at 290 nm increased little. 
This effect has also been observed previously by many research groups [42]. 
 
 
Fig. 4.5. Analysis (by Job plot) of CD spectra of 2 with a-core (A), a-coreTT (B), TBA 
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(C), c-kit (D), c-myc (E). Molar ellipticity values at 290 nm (a-core, a-coreTT, and TBA) 
and 263 nm (c-kit and c-myc) were plotted against increased ligand-DNA molar ratio. 
Experiments were performed at 25 °C in 50 mM Tris-HCl buffer pH 7.4 containing 100 
mM KCl. The intersection of data indicated the binding stoichiometry of 2 and G-
quadruplexes DNA [43]. I have observed binding stoichiometry n = 1.7 for a-core (A), n 
= 1.5 for a-coreTT (B), n = 1.8 for TBA (C), n = 2.5 for c-kit (D), n = 1.7 for c-myc (E). 
These results are consistent with the stoichiometry from UV-Vis binding studies. 
 
The Job plot analysis by CD studies (Fig. 4.5) showed that CD studies of G-
quadruplexes and 2 are consistent with binding studies where similar binding site sizes (n 
values) are obtained.  
 
4.3.3. Thermal melting Studies  
Thermal stabilization of various G-quadruplexes DNA and dsDNA in the 
presence of 2 was studied using the CD melting and UV-Vis melting experiment (Fig. 
4.6). Thermal melting of hybrid type telomeric quadruplex DNA (a-core and a-coreTT) 
was monitored at 290 nm in the presence of K+ [30].  
 
The Tm value was observed around 69 °C for a-core without 2 (Fig. 4.6A). I 
observed that the interaction of 2 with telomeric DNA quadruplex enhanced the stability 
by 15 °C for a-core and 18 °C for a-core TT, which was approximately 3 °C higher for a-
core TT than a-core G-quadruplexes DNA (Table 4.1). Researchers already reported that 
thermal melting increased after addition of base to oligonucleotides [43]. In our previous 
report [11], I observed from the absorption spectra that 1 had the lowest binding affinity 
to a-core of the sodium ion solution. Furthermore, dsDNA was monitored by UV-Vis 
melting studies. After the addition of a 2-fold concentration of 2, only a slight increase 
(up to 0.3 °C) in thermal stability was observed (Table 4.1 and Fig. 4.7). These results 
underscore the fact that 2 selectively stabilizes telomeric quadruplex DNA as well as 
promoter and thrombin binding aptamer G-quadruplex DNA over dsDNA. In comparison 
with our previous report [11], compound 2 showed high stabilizing effect to a-core and 
very weak stabilizing effect to ds DNA. 
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Fig. 4.6. Melting profiles for a-core (A); a-core TT (B); TBA (C); c-kit (D); c-myc (E) in the 
absence or presence of 2 in 50 mM Tris-HCl (pH 7.4); 100 mM KCl (A–C); 20 mM KCl 
(D); 5.0 mM KCl (E) and [ligand]:[DNA] = 2:1. 
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The melting temperatures of antiparallel chair type thrombin binding aptamer 
quadruplex DNAs (TBA) were monitored at 290 nm. Compound 2 increased the Tm of 
TBA by 11 °C (Table 4.1). These results are consistent with previously published articles 
[35,39]. The melting temperatures of parallel promoter quadruplex DNAs such as c-kit 
and c-mice were monitored at 263 NM [41,42]. In the case of the highly stable parallel c-
kit and c-myc quadruplex DNA was highly stable at high salt concentration and a stable 
baseline curve was not achieved even above 90 °C, so it is not possible to measure an 
accurate Tm in this case, so I measured Tm for c-kit and c-myc at low salt concentration. 
Compound 2 increased the Tm of c-kit by >11 °C at 20 mM K+ ion and the Tm of c-myc 
by >15 °C at 5 mM K+ ion solution (Table 4.1). This type of performance of c-kit and c-
myc is consistent with previously published articles [41,42]. According to the above 
result, I can conclude that 2 preferably stabilizes telomeric quadruplex DNA than 
promoter and thrombin binding aptamer G-quadruplex DNA. CD melting results are 
consistent with binding and competition assay studies, where 2 showed preferable binding 
to human telomeric G-quadruplex. 
 
 
 
Fig. 4.7. UV-Vis melting profiles for dsDNA (KCl) (A) and dsDNA (NaCl) (B) in 
the absence or presence of 2 in 50 mM Tris-HCl (pH 7.4) and 100 mM KCl or 100 
mM NaCl, [ligand]:[DNA] = 2:1. 
Page 103 of 117 
 
4.3.4. TRAP Assay 
Once the G-quadruplexes DNA stabilization was established for 2, it was 
important to test whether the molecule inhibits telomerase activity. To evaluate the 
abilities of these compounds to inhibit telomerase, the telomeric repeat amplification 
protocol (TRAP assay) [11,23] was carried out using various amounts of 2 (Fig. 4.8). The 
assay clearly shows that 2 is a potent inhibitor of telomerase with activity in the 
submicromolar range (IC50) 0.9 μM. This result suggests that the TS-primer extends the 
length to form a tetraplex structure and 2 binds to it and stabilizes its structure to inhibit 
the telomerase reaction. The values obtained from the TRAP assay are comparable to those 
of previously reported derivatives [11,23]. A number of small ligands have been discovered 
to inhibit the function of telomerase by stabilizing G-quadruplexes DNA structures [8]. 
The excellent IC50 for telomerase inhibition by 2 (0.9 μM) comes from its binding 
constant (K > 107 M−1). It is suggested that this macrocyclic compound 2 may deserve 
biological assays with cancer cell lines to represent a suitable candidate drug target to 
DNA quadruplexes. 
 
Fig. 4.8. Telomerase inhibition by 2. The gel shows the effect of increasing concentrations 
of 2 (0, 0.1, 0.25, 0.5, 0.75, 1.0, 2.0, 3.0, 4.0 μM) on telomerase activity. Concentrations 
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of 2.0–4.0 μM 2 lead to the disappearance of all PCR products. IC50s were determined as 
follows: ligand concentration under half telomerase activity with no ligand. 
 
4.3.5. FRET-Melting Assay 
The sequence and structural selectivity of different DNA binding agents has been 
previously explored by use of a thermodynamically rigorous competition assay procedure 
introduced by Ren and Chaires [24,45]. In this method, different nucleic acid structures are 
assayed against a common ligand solution. This is a simple method to evaluate specificity 
toward quadruplexes [46]. It has been already reported that F21T showed a Tm value 
around 50 °C [24] that increased by 11 °C after incorporation of 2 with F21T. Comparison 
with other G-quadruplexes DNA is shown in Fig. 4.9 and Fig. 4.10. Compound 2 displays 
a strong preference for binding to F21T quadruplex structure which corresponds to the 
human telomeric G-rich motif than other quadruplexes DNA structures. 
 
Fig. 4.9. FRET-melting assay of human telomeric DNA (a-coreTT), promoter 
region’s G-quadruplex (c-kit & c-myc) and thrombin-binding aptamer (TBA) with 
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F21T (0.2 µM) in the presence of 2 (0.4 µM). Experiments were performed in 100 
mM Tris-HCl buffer (pH 7.4) containing 150 mM KCl. 
 
Fig. 4.1. FRET-melting assay of human telomeric DNA (a-coreTT) (1.0 or 3.0 μM), 
promoter region’s DNA (c-kit & c-myc) (1.0 or 3.0 μM) and thrombin-binding 
aptamer (TBA) (1.0 or 3.0 μM) with F21T (0.2 μM) in the presence of 2 (0.4 μM). 
Experiments were performed at 25 °C in 100 mM Tris-HCl buffer pH 7.4 
containing 150 mM KCl. 
 
4.3.6. Computer Modeling 
The computer-modeling structures consisting of 2 with mixed hybrid types G-
quadruplex DNA (a-core) are shown in Fig. 4.11. In this article, I proposed a model 
involving an end stacking binding mode between 2 and mixed hybrid types G-quadruplex 
DNA (a-core), which are consistent with our previously published article [23]. The 
computer modeling showed that 2 stacked and bound to different G-quartet plane of 
mixed hybrid types G-quadruplex DNA (a-core). 
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Fig. 4.11. Computer modeling of 2 interactions with mixed hybrid G-quadruplex DNA 
structure (A–C). 
 
4.4. Conclusions 
I have synthesized a new type of ligand 2, carrying a benzene moiety as linker chain 
and studied its interaction with different types of G-quadruplexes DNA. I have compared 
this study with our group’s previously reported 1 [11] which has a long linker chain than 
2. Compound 2 exhibited high binding affinity in the range of 106–107 M−1 to G-
quadruplexes DNA and reduced binding affinity to dsDNA. The binding data (Table 4.1) 
indicated that 2 has 270-fold preferential binding for a-core, 165-fold for a-coreTT, 51-
fold for c-kit, 108-fold for c-myc, 95-fold for TBA over dsDNA. The binding 
stoichiometry of 2 for G-quadruplex is 2:1, suggesting a staking binding mode. 
Compound 2 revealed 200-fold higher binding selectivity compared with our previously 
reported 1 [11]. I have observed that 2 revealed preferable binding to mixed hybrid types 
structure of telomeric G-quadruplex DNA (a-core) over parallel types of promoter region’s 
G-quadruplex DNA (c-kit and c-myc) and antiparallel chair types of thrombin binding 
aptamer (TBA). The CD spectra showed that 2 stabilized G-quadruplexes DNA structure. 
Upon the addition of 2 to a-core the CD spectra showed little change indicating a mixed 
hybrid structure and little changed to the hybrid-1 type G-quadruplex structure [38]. Thermal 
melting measurements indicated that 2 highly stabilized the G-quadruplexes DNA 
structure. Compared with our previous report [11], 2 increased ∆Tm by 5–8 °C. I have 
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performed competitive assays in order to determine the binding selectivity among the G-
quadruplexes DNA, and 2 showed highly preferable stabilization of human telomeric G-
quadruplex sequence (F21T). This novel compound 2 can also inhibit the telomerase 
activity at low submicromolar concentrations. These results indicated that 2 is an 
important class of G-quadruplex stabilizing ligand compared with dsDNA. 
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Conclusions and Perspectives 
 
Contents of this chapter have been published in the Bioorgamic & Medicinal chemistry 
Journal and Molecules Journal (M.M. Islam, S. Fujii, S. Sato, T. Okauchi, S. Takenaka, 
Bioorganic Med. Chem. 23 (2015) 4769–4776 and M.M. Islam, S. Fujii, S. Sato, T. 
Okauchi, S. Takenaka, Molecules, 20 (2015) 10963-10979). The materials of the chapter 
have been reproduced with the permission of the Bioorgamic & Medicinal chemistry 
Journal and Molecule Journal [1,2]. 
 
The stabilization of a specific DNA sequences with small molecule is leading to the 
development of therapeutics. These small molecules bind with target DNA sequences and 
regulate the gene expression [3-6]. Recently, DNA secondary structure such as G-
quadruplexes DNA stabilizing with small ligand molecules is now considered as a 
promising target for the development of anticancer drugs [3]. But the selectivity of ligands 
binding to G-quadruplexes DNA still now are controversial. So, the designing and 
development of more specific ligands for G-quadruplexes DNA stabilization are crucial. 
 
In my doctoral thesis, I have presented two different types of cNDIs (1,2) as a new 
DNA interactive compounds which I dealt with during my doctoral research. In particular, 
my effort have been directed towards synthesis and design of two new cNDIs, one cyclic 
linker chain was designed by piperazine and amide group through the benzene ring named 
Page 113 of 117 
 
as cNDI 1. Another type of cyclic linker chain was designed by tertiary amine and amide 
group through the benzene ring named as cNDI 2.  
 
Subsequently, in order to evaluate the activity of the newly synthesized molecules, I 
have studied their ability in binding and stabilizing different types of DNA such as 
dsDNA (calf thymus DNA (CT-DNA), poly[d(A-T)]2, or poly[d(G-C)]2) and G-
quadruplex DNA (a-core and a-core TT as a human telomeric DNA, c-kit and c-myc as 
DNA sequence at promoter region, or thrombin binding aptamer (TBA)) structure as well 
as their selectivity towards G-quadruplexes DNA with respect to duplex DNA. To these 
aims, several experimental techniques have been used such as UV-Vis spectroscopy, 
Circular Dichroism (CD) spectroscopy, Stopped-flow kinetics, Topoisomerase I assay, 
Thermal melting stability, FRET-melting assay, TRAP assay and computer modeling 
studies.  
 
Firstly, I have studied the comparison of the interaction of studies between 1 and 2 
with dsDNA. Using UV-Vis studies, I have found high binding affinity of 1 to dsDNA in 
the range of 6×105-5.3×106 M-1 with covering four base pairs of DNA per molecule, 
which are approximately 10 times higher than 2. The binding studies of 1 with poly[d(G-
C)]2 indicated approximately 5 times higher than 3, where 3 covered two base pairs of 
DNA as threading intercalator. Thermodynamic studies of 1 and 2 indicated the 
endothermic and entropy dependent hydrophobic interaction played major role in the 
reaction. Compound 1 showed more entropically favorable than 2, whereas 3 showed 
exodothermic and enthalpy dependent binding to CT-DNA played main role in the 
interactions. The analysis of salt ion effect showed that the high salt concentration reduced 
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the binding of cNDIs with CT-DNA. Kinetics studies of 1 and 2 indicated that 1 slowly 
dissociated from GC base pair than 2, which comes from the unique bis-intercalative 
binding mode like a catenane formation with stairs of double stranded DNA. The CD 
spectra indicated that 2 can induce the CT-DNA structure. The Topoisomerase I 
unwinding assay of circular dsDNA further supported favorable bis-intercalation binding 
of 1 than 2.  
 
Secondly, I have studied the interaction of 2 and 3 with different types of G-
quadruplexes DNA and compared this study with our previously reported 1 [7] which 
have long linker chain than 2. Compound 2 revealed high binding affinity in the range of 
106-107 M-1 to G-quadruplexes DNA whereas reducing the binding affinity with dsDNA. 
Compound 2 revealed 6 times higher binding constant than 3 with a-core G-quadruplex 
DNA. The binding data indicated that 2 has 270 times preferable binding for a-core, 165 
times for a-core TT, 51 times for c-kit, 108 times for c-myc, 95 times for TBA over 
dsDNA. The binding stoichiometry of cNDI-G-quardruplex is 2:1, suggesting an end 
staking binding mode. Compound 2 revealed 200 times binding selectivity over our 
previously reported 1 [7]. I have observed that 2 showed better binding to telomeric mixed 
hybrid types of a-core G-quadrulex DNA over promoter region’s parallel types of c-kit 
and c-myc G-quadrulex DNA and thrombin binding aptamer (TBA) antiparallel chair 
types of G-quadrulex DNA. The CD spectra showed cNDI molecule induced G-
quardruplexes DNA structure which also indicated the end staking interaction between 
cNDIs and G-quadruplexes DNA. Upon the addition of 2 to a-core G-quadruplex DNA, 
CD spectra conformation little changed indicating mixed hybrid structure a little changed 
to hybrid-1 types G-quadruplex DNA structure [8]. Thermal melting measurement 
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indicated that 2 highly stabilized with the G-quardruplexes DNA structure. Comparing 
with 1 [5], 2 increased △Tm by 5-8 ﾟ C. The FRET melting assay was measured to 
determine the competitive binding among the G-quardruplexes DNA, the result showed 
2 highly preferable stabilization to F21T which is the generated from the human telomeric 
G-quardruplex DNA sequences. This novel 2 can also inhibit the telomerase activity at 
low sub-micro-molar (0.9 μM) concentration. The results indicated that 2 is an important 
class of G-quadruplex stabilizing ligands compared with dsDNA. 
 
The interesting result from biochemical, biophysical and biological points of view, 
encourage further development of cNDIs derivatives to find out more specific binding G-
quadruplexes ligands. These newly design cNDIs deserve for further analysis of the 
mechanisms of action inside the cancer cell lines by these compounds, due to G-
quadruplexes binding drug candidate and the possible pharmacological applications.  
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